JP7489136B2 - Liver function improver - Google Patents
Liver function improver Download PDFInfo
- Publication number
- JP7489136B2 JP7489136B2 JP2023014833A JP2023014833A JP7489136B2 JP 7489136 B2 JP7489136 B2 JP 7489136B2 JP 2023014833 A JP2023014833 A JP 2023014833A JP 2023014833 A JP2023014833 A JP 2023014833A JP 7489136 B2 JP7489136 B2 JP 7489136B2
- Authority
- JP
- Japan
- Prior art keywords
- parts
- fermented
- ginger
- weight
- mass
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000003908 liver function Effects 0.000 title claims description 103
- 235000006886 Zingiber officinale Nutrition 0.000 claims description 169
- 235000008397 ginger Nutrition 0.000 claims description 169
- 239000003795 chemical substances by application Substances 0.000 claims description 36
- PEYUIKBAABKQKQ-AFHBHXEDSA-N (+)-sesamin Chemical compound C1=C2OCOC2=CC([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-AFHBHXEDSA-N 0.000 claims description 5
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 claims description 5
- PEYUIKBAABKQKQ-UHFFFAOYSA-N epiasarinin Natural products C1=C2OCOC2=CC(C2OCC3C2COC3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-UHFFFAOYSA-N 0.000 claims description 5
- VRMHCMWQHAXTOR-CMOCDZPBSA-N sesamin Natural products C1=C2OCOC2=CC([C@@H]2OC[C@@]3(C)[C@H](C=4C=C5OCOC5=CC=4)OC[C@]32C)=C1 VRMHCMWQHAXTOR-CMOCDZPBSA-N 0.000 claims description 5
- 235000002789 Panax ginseng Nutrition 0.000 claims description 4
- 235000019510 Long pepper Nutrition 0.000 claims description 3
- 240000003455 Piper longum Species 0.000 claims description 3
- 244000273928 Zingiber officinale Species 0.000 claims description 3
- 240000008384 Capsicum annuum var. annuum Species 0.000 claims description 2
- 241000234314 Zingiber Species 0.000 description 172
- 239000000284 extract Substances 0.000 description 61
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 60
- 239000000843 powder Substances 0.000 description 50
- 239000004615 ingredient Substances 0.000 description 47
- 239000000203 mixture Substances 0.000 description 47
- 240000006439 Aspergillus oryzae Species 0.000 description 41
- 235000002247 Aspergillus oryzae Nutrition 0.000 description 41
- 230000000694 effects Effects 0.000 description 40
- 239000000047 product Substances 0.000 description 39
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 34
- 241000196324 Embryophyta Species 0.000 description 29
- 238000000855 fermentation Methods 0.000 description 28
- 230000002195 synergetic effect Effects 0.000 description 28
- 235000019640 taste Nutrition 0.000 description 28
- 230000004151 fermentation Effects 0.000 description 27
- 239000007788 liquid Substances 0.000 description 22
- 238000002156 mixing Methods 0.000 description 22
- 238000009472 formulation Methods 0.000 description 21
- 235000002780 gingerol Nutrition 0.000 description 21
- 238000004519 manufacturing process Methods 0.000 description 21
- 241000234299 Zingiberaceae Species 0.000 description 20
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 18
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 18
- 239000002994 raw material Substances 0.000 description 18
- 238000012360 testing method Methods 0.000 description 18
- 238000000034 method Methods 0.000 description 17
- 239000008187 granular material Substances 0.000 description 16
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 15
- 238000010438 heat treatment Methods 0.000 description 15
- 235000019633 pungent taste Nutrition 0.000 description 15
- 239000002904 solvent Substances 0.000 description 15
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 14
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 14
- 239000000463 material Substances 0.000 description 14
- 235000013305 food Nutrition 0.000 description 13
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 12
- 210000004027 cell Anatomy 0.000 description 12
- 230000000052 comparative effect Effects 0.000 description 12
- 230000002349 favourable effect Effects 0.000 description 12
- 239000002775 capsule Substances 0.000 description 11
- 239000000796 flavoring agent Substances 0.000 description 11
- 235000019634 flavors Nutrition 0.000 description 11
- 230000002538 fungal effect Effects 0.000 description 11
- 239000000243 solution Substances 0.000 description 11
- 241000894006 Bacteria Species 0.000 description 10
- 240000007594 Oryza sativa Species 0.000 description 10
- 235000007164 Oryza sativa Nutrition 0.000 description 10
- 235000002595 Solanum tuberosum Nutrition 0.000 description 10
- 244000061456 Solanum tuberosum Species 0.000 description 10
- 244000269722 Thea sinensis Species 0.000 description 10
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 10
- 235000009566 rice Nutrition 0.000 description 10
- 239000003826 tablet Substances 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- 235000013361 beverage Nutrition 0.000 description 9
- 235000013399 edible fruits Nutrition 0.000 description 9
- 230000007774 longterm Effects 0.000 description 9
- 239000002609 medium Substances 0.000 description 9
- 230000006872 improvement Effects 0.000 description 8
- 239000006210 lotion Substances 0.000 description 8
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 8
- 239000008213 purified water Substances 0.000 description 8
- 239000000344 soap Substances 0.000 description 8
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 8
- 241000233866 Fungi Species 0.000 description 7
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 7
- 238000000605 extraction Methods 0.000 description 7
- 239000003205 fragrance Substances 0.000 description 7
- 235000011187 glycerol Nutrition 0.000 description 7
- 239000004310 lactic acid Substances 0.000 description 7
- 235000014655 lactic acid Nutrition 0.000 description 7
- 235000020741 pine bark extract Nutrition 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 230000001737 promoting effect Effects 0.000 description 7
- 235000013599 spices Nutrition 0.000 description 7
- OQWKEEOHDMUXEO-UHFFFAOYSA-N (6)-shogaol Natural products CCCCCC=CC(=O)CCC1=CC=C(O)C(OC)=C1 OQWKEEOHDMUXEO-UHFFFAOYSA-N 0.000 description 6
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- 241000228212 Aspergillus Species 0.000 description 6
- 241000723377 Coffea Species 0.000 description 6
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
- 244000046146 Pueraria lobata Species 0.000 description 6
- 235000010575 Pueraria lobata Nutrition 0.000 description 6
- 229920002125 Sokalan® Polymers 0.000 description 6
- OQWKEEOHDMUXEO-BQYQJAHWSA-N [6]-Shogaol Chemical compound CCCCC\C=C\C(=O)CCC1=CC=C(O)C(OC)=C1 OQWKEEOHDMUXEO-BQYQJAHWSA-N 0.000 description 6
- 235000019437 butane-1,3-diol Nutrition 0.000 description 6
- 239000008278 cosmetic cream Substances 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 239000000839 emulsion Substances 0.000 description 6
- NLDDIKRKFXEWBK-AWEZNQCLSA-N gingerol Chemical compound CCCCC[C@H](O)CC(=O)CCC1=CC=C(O)C(OC)=C1 NLDDIKRKFXEWBK-AWEZNQCLSA-N 0.000 description 6
- JZLXEKNVCWMYHI-UHFFFAOYSA-N gingerol Natural products CCCCC(O)CC(=O)CCC1=CC=C(O)C(OC)=C1 JZLXEKNVCWMYHI-UHFFFAOYSA-N 0.000 description 6
- 239000002453 shampoo Substances 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 244000241872 Lycium chinense Species 0.000 description 5
- 241000220317 Rosa Species 0.000 description 5
- 235000006468 Thea sinensis Nutrition 0.000 description 5
- 235000013339 cereals Nutrition 0.000 description 5
- 229940088598 enzyme Drugs 0.000 description 5
- 239000013538 functional additive Substances 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 235000019198 oils Nutrition 0.000 description 5
- 229940106587 pine bark extract Drugs 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 235000013322 soy milk Nutrition 0.000 description 5
- 235000013616 tea Nutrition 0.000 description 5
- 229940058015 1,3-butylene glycol Drugs 0.000 description 4
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 4
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 4
- 240000006891 Artemisia vulgaris Species 0.000 description 4
- 240000006914 Aspalathus linearis Species 0.000 description 4
- 241000951471 Citrus junos Species 0.000 description 4
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 4
- 235000010469 Glycine max Nutrition 0.000 description 4
- 244000068988 Glycine max Species 0.000 description 4
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 4
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 4
- 235000015459 Lycium barbarum Nutrition 0.000 description 4
- 235000015468 Lycium chinense Nutrition 0.000 description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- 244000046052 Phaseolus vulgaris Species 0.000 description 4
- 235000009330 Terminalia Nutrition 0.000 description 4
- 241001534869 Terminalia Species 0.000 description 4
- 244000191422 Terminalia bellirica Species 0.000 description 4
- 235000012023 Terminalia bellirica Nutrition 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 4
- 230000004913 activation Effects 0.000 description 4
- 229940024606 amino acid Drugs 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 235000020279 black tea Nutrition 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 4
- 230000020411 cell activation Effects 0.000 description 4
- 239000001913 cellulose Substances 0.000 description 4
- 229920002678 cellulose Polymers 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 238000012790 confirmation Methods 0.000 description 4
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000003925 fat Substances 0.000 description 4
- 235000019197 fats Nutrition 0.000 description 4
- 210000003494 hepatocyte Anatomy 0.000 description 4
- 239000008101 lactose Substances 0.000 description 4
- 210000005229 liver cell Anatomy 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 4
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 4
- 229960002216 methylparaben Drugs 0.000 description 4
- 235000013336 milk Nutrition 0.000 description 4
- 239000008267 milk Substances 0.000 description 4
- 210000004080 milk Anatomy 0.000 description 4
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 4
- 235000008390 olive oil Nutrition 0.000 description 4
- 239000004006 olive oil Substances 0.000 description 4
- 229960005323 phenoxyethanol Drugs 0.000 description 4
- 235000020339 pu-erh tea Nutrition 0.000 description 4
- 239000001509 sodium citrate Substances 0.000 description 4
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 4
- 229940032094 squalane Drugs 0.000 description 4
- 208000022309 Alcoholic Liver disease Diseases 0.000 description 3
- 244000291564 Allium cepa Species 0.000 description 3
- 241001513093 Aspergillus awamori Species 0.000 description 3
- 244000063299 Bacillus subtilis Species 0.000 description 3
- 235000014469 Bacillus subtilis Nutrition 0.000 description 3
- 235000002568 Capsicum frutescens Nutrition 0.000 description 3
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 3
- 241000220485 Fabaceae Species 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 244000294611 Punica granatum Species 0.000 description 3
- 235000014360 Punica granatum Nutrition 0.000 description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- 244000062793 Sorghum vulgare Species 0.000 description 3
- 108010073771 Soybean Proteins Proteins 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 3
- 235000013734 beta-carotene Nutrition 0.000 description 3
- 239000011648 beta-carotene Substances 0.000 description 3
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 3
- 229960002747 betacarotene Drugs 0.000 description 3
- 210000000941 bile Anatomy 0.000 description 3
- 235000017803 cinnamon Nutrition 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 235000012754 curcumin Nutrition 0.000 description 3
- 239000004148 curcumin Substances 0.000 description 3
- 229940109262 curcumin Drugs 0.000 description 3
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 229940089161 ginsenoside Drugs 0.000 description 3
- 229930182494 ginsenoside Natural products 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 230000002440 hepatic effect Effects 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- 229960003284 iron Drugs 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 210000005228 liver tissue Anatomy 0.000 description 3
- 235000014571 nuts Nutrition 0.000 description 3
- MXXWOMGUGJBKIW-YPCIICBESA-N piperine Chemical compound C=1C=C2OCOC2=CC=1/C=C/C=C/C(=O)N1CCCCC1 MXXWOMGUGJBKIW-YPCIICBESA-N 0.000 description 3
- 229940075559 piperine Drugs 0.000 description 3
- 235000019100 piperine Nutrition 0.000 description 3
- WVWHRXVVAYXKDE-UHFFFAOYSA-N piperine Natural products O=C(C=CC=Cc1ccc2OCOc2c1)C3CCCCN3 WVWHRXVVAYXKDE-UHFFFAOYSA-N 0.000 description 3
- 230000029058 respiratory gaseous exchange Effects 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- -1 shortening Substances 0.000 description 3
- 229940001941 soy protein Drugs 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 230000003612 virological effect Effects 0.000 description 3
- 239000000230 xanthan gum Substances 0.000 description 3
- 229920001285 xanthan gum Polymers 0.000 description 3
- 235000010493 xanthan gum Nutrition 0.000 description 3
- 229940082509 xanthan gum Drugs 0.000 description 3
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 3
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 2
- PJVXUVWGSCCGHT-ZPYZYFCMSA-N (2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal;(3s,4r,5r)-1,3,4,5,6-pentahydroxyhexan-2-one Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO PJVXUVWGSCCGHT-ZPYZYFCMSA-N 0.000 description 2
- 229940043375 1,5-pentanediol Drugs 0.000 description 2
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 2
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 2
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 2
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 2
- 239000005995 Aluminium silicate Substances 0.000 description 2
- 241000122821 Aspergillus kawachii Species 0.000 description 2
- 241000228245 Aspergillus niger Species 0.000 description 2
- 241000228251 Aspergillus phoenicis Species 0.000 description 2
- 241001112078 Aspergillus usamii Species 0.000 description 2
- 240000007124 Brassica oleracea Species 0.000 description 2
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 2
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 2
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 2
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 2
- 102000029816 Collagenase Human genes 0.000 description 2
- 108060005980 Collagenase Proteins 0.000 description 2
- 229920002261 Corn starch Polymers 0.000 description 2
- 235000003392 Curcuma domestica Nutrition 0.000 description 2
- 244000008991 Curcuma longa Species 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- GZIFEOYASATJEH-UHFFFAOYSA-N D-delta tocopherol Natural products OC1=CC(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 GZIFEOYASATJEH-UHFFFAOYSA-N 0.000 description 2
- 244000239348 Echinochloa crus galli var. praticola Species 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 240000005979 Hordeum vulgare Species 0.000 description 2
- 235000007340 Hordeum vulgare Nutrition 0.000 description 2
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 2
- IPMYMEWFZKHGAX-UHFFFAOYSA-N Isotheaflavin Natural products OC1CC2=C(O)C=C(O)C=C2OC1C(C1=C2)=CC(O)=C(O)C1=C(O)C(=O)C=C2C1C(O)CC2=C(O)C=C(O)C=C2O1 IPMYMEWFZKHGAX-UHFFFAOYSA-N 0.000 description 2
- 235000019766 L-Lysine Nutrition 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
- 229930182844 L-isoleucine Natural products 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- 240000008415 Lactuca sativa Species 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 2
- 235000005205 Pinus Nutrition 0.000 description 2
- 241000218602 Pinus <genus> Species 0.000 description 2
- 241001236212 Pinus pinaster Species 0.000 description 2
- 235000005105 Pinus pinaster Nutrition 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 235000004789 Rosa xanthina Nutrition 0.000 description 2
- 240000005498 Setaria italica Species 0.000 description 2
- 229920001800 Shellac Polymers 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 229920002385 Sodium hyaluronate Polymers 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- 239000004376 Sucralose Substances 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 241000001522 Terminalia chebula Species 0.000 description 2
- 235000011517 Terminalia chebula Nutrition 0.000 description 2
- UXRMWRBWCAGDQB-UHFFFAOYSA-N Theaflavin Natural products C1=CC(C2C(CC3=C(O)C=C(O)C=C3O2)O)=C(O)C(=O)C2=C1C(C1OC3=CC(O)=CC(O)=C3CC1O)=CC(O)=C2O UXRMWRBWCAGDQB-UHFFFAOYSA-N 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 244000098338 Triticum aestivum Species 0.000 description 2
- 229930003451 Vitamin B1 Natural products 0.000 description 2
- 229930003471 Vitamin B2 Natural products 0.000 description 2
- 229930003448 Vitamin K Natural products 0.000 description 2
- 235000010358 acesulfame potassium Nutrition 0.000 description 2
- 229960004998 acesulfame potassium Drugs 0.000 description 2
- 239000000619 acesulfame-K Substances 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- 235000012211 aluminium silicate Nutrition 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 229960001948 caffeine Drugs 0.000 description 2
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 2
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 2
- 235000013539 calcium stearate Nutrition 0.000 description 2
- 239000008116 calcium stearate Substances 0.000 description 2
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 2
- 229960001631 carbomer Drugs 0.000 description 2
- 239000007765 cera alba Substances 0.000 description 2
- 229940074393 chlorogenic acid Drugs 0.000 description 2
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 2
- 235000001368 chlorogenic acid Nutrition 0.000 description 2
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 2
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 2
- MRUAUOIMASANKQ-UHFFFAOYSA-N cocamidopropyl betaine Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 description 2
- 229940073507 cocamidopropyl betaine Drugs 0.000 description 2
- 229960002424 collagenase Drugs 0.000 description 2
- 239000008120 corn starch Substances 0.000 description 2
- 229940099112 cornstarch Drugs 0.000 description 2
- 235000003373 curcuma longa Nutrition 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 229940105990 diglycerin Drugs 0.000 description 2
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 2
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 229960000735 docosanol Drugs 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 235000013376 functional food Nutrition 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 230000036252 glycation Effects 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 229960000310 isoleucine Drugs 0.000 description 2
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 235000021374 legumes Nutrition 0.000 description 2
- 238000009630 liquid culture Methods 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 235000019713 millet Nutrition 0.000 description 2
- 235000012149 noodles Nutrition 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 229940073665 octyldodecyl myristate Drugs 0.000 description 2
- 239000005416 organic matter Substances 0.000 description 2
- 235000002252 panizo Nutrition 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 2
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 2
- 229920001451 polypropylene glycol Polymers 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 235000021395 porridge Nutrition 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- MMXZSJMASHPLLR-UHFFFAOYSA-N pyrroloquinoline quinone Chemical compound C12=C(C(O)=O)C=C(C(O)=O)N=C2C(=O)C(=O)C2=C1NC(C(=O)O)=C2 MMXZSJMASHPLLR-UHFFFAOYSA-N 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 235000015067 sauces Nutrition 0.000 description 2
- 238000013207 serial dilution Methods 0.000 description 2
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 description 2
- 239000004208 shellac Substances 0.000 description 2
- 235000013874 shellac Nutrition 0.000 description 2
- 229940113147 shellac Drugs 0.000 description 2
- 229920002545 silicone oil Polymers 0.000 description 2
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 2
- 239000004299 sodium benzoate Substances 0.000 description 2
- 235000010234 sodium benzoate Nutrition 0.000 description 2
- 229940010747 sodium hyaluronate Drugs 0.000 description 2
- 229940057950 sodium laureth sulfate Drugs 0.000 description 2
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 2
- SXHLENDCVBIJFO-UHFFFAOYSA-M sodium;2-[2-(2-dodecoxyethoxy)ethoxy]ethyl sulfate Chemical compound [Na+].CCCCCCCCCCCCOCCOCCOCCOS([O-])(=O)=O SXHLENDCVBIJFO-UHFFFAOYSA-M 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 235000019408 sucralose Nutrition 0.000 description 2
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 239000012085 test solution Substances 0.000 description 2
- KWXLCDNSEHTOCB-UHFFFAOYSA-J tetrasodium;1,1-diphosphonatoethanol Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P(=O)([O-])C(O)(C)P([O-])([O-])=O KWXLCDNSEHTOCB-UHFFFAOYSA-J 0.000 description 2
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 description 2
- 229940026509 theaflavin Drugs 0.000 description 2
- IPMYMEWFZKHGAX-ZKSIBHASSA-N theaflavin Chemical compound C1=C2C([C@H]3OC4=CC(O)=CC(O)=C4C[C@H]3O)=CC(O)=C(O)C2=C(O)C(=O)C=C1[C@@H]1[C@H](O)CC2=C(O)C=C(O)C=C2O1 IPMYMEWFZKHGAX-ZKSIBHASSA-N 0.000 description 2
- 235000014620 theaflavin Nutrition 0.000 description 2
- 229960003495 thiamine Drugs 0.000 description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 235000013976 turmeric Nutrition 0.000 description 2
- 235000010374 vitamin B1 Nutrition 0.000 description 2
- 239000011691 vitamin B1 Substances 0.000 description 2
- 235000019164 vitamin B2 Nutrition 0.000 description 2
- 239000011716 vitamin B2 Substances 0.000 description 2
- 235000019168 vitamin K Nutrition 0.000 description 2
- 239000011712 vitamin K Substances 0.000 description 2
- 150000003721 vitamin K derivatives Chemical class 0.000 description 2
- 229940046010 vitamin k Drugs 0.000 description 2
- GZIFEOYASATJEH-VHFRWLAGSA-N δ-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 GZIFEOYASATJEH-VHFRWLAGSA-N 0.000 description 2
- 240000005020 Acaciella glauca Species 0.000 description 1
- 241000589220 Acetobacter Species 0.000 description 1
- 241001478307 Acidomonas Species 0.000 description 1
- 241000193798 Aerococcus Species 0.000 description 1
- 244000066764 Ailanthus triphysa Species 0.000 description 1
- 235000010167 Allium cepa var aggregatum Nutrition 0.000 description 1
- 235000018645 Allium odorum Nutrition 0.000 description 1
- 244000003377 Allium tuberosum Species 0.000 description 1
- 235000005338 Allium tuberosum Nutrition 0.000 description 1
- 241000583531 Alpinia purpurata Species 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 244000226021 Anacardium occidentale Species 0.000 description 1
- 240000007087 Apium graveolens Species 0.000 description 1
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 description 1
- 235000010591 Appio Nutrition 0.000 description 1
- 235000007650 Aralia spinosa Nutrition 0.000 description 1
- 244000118154 Aralia spinosa Species 0.000 description 1
- 240000005528 Arctium lappa Species 0.000 description 1
- 235000003130 Arctium lappa Nutrition 0.000 description 1
- 235000008078 Arctium minus Nutrition 0.000 description 1
- 235000004355 Artemisia lactiflora Nutrition 0.000 description 1
- 241000308413 Asaia Species 0.000 description 1
- 241001219293 Aspalathus Species 0.000 description 1
- 244000286893 Aspalathus contaminatus Species 0.000 description 1
- 235000012984 Aspalathus linearis Nutrition 0.000 description 1
- 235000005638 Austrian pine Nutrition 0.000 description 1
- 241000304886 Bacilli Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000167854 Bourreria succulenta Species 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 235000011293 Brassica napus Nutrition 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000017647 Brassica oleracea var italica Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- 235000012905 Brassica oleracea var viridis Nutrition 0.000 description 1
- 235000000540 Brassica rapa subsp rapa Nutrition 0.000 description 1
- 241000722885 Brettanomyces Species 0.000 description 1
- 235000019224 Camellia sinensis var Qingmao Nutrition 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 241000206594 Carnobacterium Species 0.000 description 1
- 235000014036 Castanea Nutrition 0.000 description 1
- 241001070941 Castanea Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 241001481833 Coryphaena hippurus Species 0.000 description 1
- 241001337994 Cryptococcus <scale insect> Species 0.000 description 1
- 241000371652 Curvularia clavata Species 0.000 description 1
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 1
- 235000018782 Dacrydium cupressinum Nutrition 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 241000235035 Debaryomyces Species 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 241000723267 Diospyros Species 0.000 description 1
- 235000011511 Diospyros Nutrition 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 241000194033 Enterococcus Species 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 244000062245 Hedychium flavescens Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- 244000017020 Ipomoea batatas Species 0.000 description 1
- 235000002678 Ipomoea batatas Nutrition 0.000 description 1
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 1
- 241000758791 Juglandaceae Species 0.000 description 1
- 241000235649 Kluyveromyces Species 0.000 description 1
- QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- 239000004158 L-cystine Substances 0.000 description 1
- 235000019393 L-cystine Nutrition 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- 229930182816 L-glutamine Natural products 0.000 description 1
- 229930182821 L-proline Natural products 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 241000194036 Lactococcus Species 0.000 description 1
- 235000003228 Lactuca sativa Nutrition 0.000 description 1
- 241000218652 Larix Species 0.000 description 1
- 235000005590 Larix decidua Nutrition 0.000 description 1
- 240000000599 Lentinula edodes Species 0.000 description 1
- 241000192132 Leuconostoc Species 0.000 description 1
- 241001149698 Lipomyces Species 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 241000208467 Macadamia Species 0.000 description 1
- 244000070406 Malus silvestris Species 0.000 description 1
- 241001123674 Metschnikowia Species 0.000 description 1
- 235000015429 Mirabilis expansa Nutrition 0.000 description 1
- 244000294411 Mirabilis expansa Species 0.000 description 1
- 235000009811 Momordica charantia Nutrition 0.000 description 1
- 244000302512 Momordica charantia Species 0.000 description 1
- 240000005561 Musa balbisiana Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 241000192001 Pediococcus Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 241000235648 Pichia Species 0.000 description 1
- 235000008565 Pinus banksiana Nutrition 0.000 description 1
- 244000019397 Pinus jeffreyi Species 0.000 description 1
- 235000013264 Pinus jeffreyi Nutrition 0.000 description 1
- 235000013697 Pinus resinosa Nutrition 0.000 description 1
- 235000008578 Pinus strobus Nutrition 0.000 description 1
- 235000008585 Pinus thunbergii Nutrition 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 244000203593 Piper nigrum Species 0.000 description 1
- 235000010582 Pisum sativum Nutrition 0.000 description 1
- 240000004713 Pisum sativum Species 0.000 description 1
- 235000014030 Podocarpus spicatus Nutrition 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- 240000005809 Prunus persica Species 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 241000219780 Pueraria Species 0.000 description 1
- 241000220324 Pyrus Species 0.000 description 1
- 244000088415 Raphanus sativus Species 0.000 description 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 1
- 241000109329 Rosa xanthina Species 0.000 description 1
- 241000220222 Rosaceae Species 0.000 description 1
- 241001107098 Rubiaceae Species 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 241000235346 Schizosaccharomyces Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 244000040738 Sesamum orientale Species 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 235000002597 Solanum melongena Nutrition 0.000 description 1
- 244000061458 Solanum melongena Species 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- 235000009337 Spinacia oleracea Nutrition 0.000 description 1
- 244000300264 Spinacia oleracea Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 235000021536 Sugar beet Nutrition 0.000 description 1
- 244000100103 Terminalia arborea Species 0.000 description 1
- 235000000538 Terminalia arjuna Nutrition 0.000 description 1
- 244000071109 Terminalia arjuna Species 0.000 description 1
- 235000009319 Terminalia catappa Nutrition 0.000 description 1
- 244000277583 Terminalia catappa Species 0.000 description 1
- 235000018723 Terminalia ivorensis Nutrition 0.000 description 1
- 241001284285 Terminalia ivorensis Species 0.000 description 1
- 241001610940 Terminalia phellocarpa Species 0.000 description 1
- 241001431476 Terminalia superba Species 0.000 description 1
- 235000005212 Terminalia tomentosa Nutrition 0.000 description 1
- 244000125380 Terminalia tomentosa Species 0.000 description 1
- 241000500334 Tetragenococcus Species 0.000 description 1
- 241000235006 Torulaspora Species 0.000 description 1
- 235000011453 Vigna umbellata Nutrition 0.000 description 1
- 240000001417 Vigna umbellata Species 0.000 description 1
- 241000219094 Vitaceae Species 0.000 description 1
- 229930003537 Vitamin B3 Natural products 0.000 description 1
- 235000009932 Zanthoxylum simulans Nutrition 0.000 description 1
- 244000089698 Zanthoxylum simulans Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 241000235017 Zygosaccharomyces Species 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 229960003767 alanine Drugs 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- 235000021016 apples Nutrition 0.000 description 1
- 235000015173 baked goods and baking mixes Nutrition 0.000 description 1
- 235000021015 bananas Nutrition 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 235000013614 black pepper Nutrition 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 235000021329 brown rice Nutrition 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000007894 caplet Substances 0.000 description 1
- 235000017663 capsaicin Nutrition 0.000 description 1
- 229960002504 capsaicin Drugs 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 235000020226 cashew nut Nutrition 0.000 description 1
- 238000010609 cell counting kit-8 assay Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000019693 cherries Nutrition 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 235000005897 citrine myrobalan Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229920002770 condensed tannin Polymers 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 235000020247 cow milk Nutrition 0.000 description 1
- 235000015140 cultured milk Nutrition 0.000 description 1
- 235000021438 curry Nutrition 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 235000011850 desserts Nutrition 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229960002989 glutamic acid Drugs 0.000 description 1
- 229960002743 glutamine Drugs 0.000 description 1
- 235000021021 grapes Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 229920000591 gum Polymers 0.000 description 1
- 235000015220 hamburgers Nutrition 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 231100000234 hepatic damage Toxicity 0.000 description 1
- 206010073071 hepatocellular carcinoma Diseases 0.000 description 1
- 229960002885 histidine Drugs 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 235000008446 instant noodles Nutrition 0.000 description 1
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 235000013490 limbo Nutrition 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 230000008818 liver damage Effects 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 229960003646 lysine Drugs 0.000 description 1
- 235000013310 margarine Nutrition 0.000 description 1
- 239000003264 margarine Substances 0.000 description 1
- 239000008268 mayonnaise Substances 0.000 description 1
- 235000010746 mayonnaise Nutrition 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 235000013536 miso Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 235000021017 pears Nutrition 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 235000012015 potatoes Nutrition 0.000 description 1
- 235000008476 powdered milk Nutrition 0.000 description 1
- 229960002429 proline Drugs 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- 235000017985 rocky mountain lodgepole pine Nutrition 0.000 description 1
- 235000020330 rooibos tea Nutrition 0.000 description 1
- 235000019992 sake Nutrition 0.000 description 1
- 235000012045 salad Nutrition 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 235000014102 seafood Nutrition 0.000 description 1
- 229960001153 serine Drugs 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 235000013570 smoothie Nutrition 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 235000013555 soy sauce Nutrition 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 235000013547 stew Nutrition 0.000 description 1
- 235000021012 strawberries Nutrition 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- 229960004441 tyrosine Drugs 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 235000019160 vitamin B3 Nutrition 0.000 description 1
- 239000011708 vitamin B3 Substances 0.000 description 1
- 235000020234 walnut Nutrition 0.000 description 1
- 239000008256 whipped cream Substances 0.000 description 1
- 235000013636 white bombway Nutrition 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- General Preparation And Processing Of Foods (AREA)
- Non-Alcoholic Beverages (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Description
本発明は、肝機能改善剤に関し、詳しくは、発酵ショウガ及び特定の他成分を含むことを特徴とする肝機能改善剤に関する。 The present invention relates to a liver function improving agent, and more specifically, to a liver function improving agent that contains fermented ginger and other specific ingredients.
ショウガ科植物は、薬用や食用として広く用いられ、その血行促進作用(特許文献1)は昔から知られており、その他にも女性の冷え性、生理痛、便秘・肥満等の改善などの作用(特許文献2)が知られている。最近、ショウガを発酵させた発酵ショウガが着目されているが、その作用については研究が十分なされていない。 Zingiberaceae plants are widely used for medicinal and edible purposes, and their blood circulation promoting effect (Patent Document 1) has long been known. They are also known to have other effects such as improving poor circulation, menstrual pain, constipation, and obesity in women (Patent Document 2). Recently, fermented ginger, which is made by fermenting ginger, has been attracting attention, but its effects have not been sufficiently researched.
本発明者らは、発酵ショウガと多種多様な他成分とを組み合わせて、肝機能改善作用を確認したところ、特定の組み合わせにおいて、発酵ショウガ単独又は特定の他成分単独の肝機能改善能と比して、肝機能改善能が飛躍的に向上することを見いだし、本発明を完成するに至った。すなわち、発酵ショウガと、特定の他成分を組み合わせることにより、肝機能改善能を相乗的に向上させることができることを見いだした。 The inventors have confirmed the liver function improving effect by combining fermented ginger with a wide variety of other ingredients, and have found that in certain combinations, the liver function improving ability is dramatically improved compared to the liver function improving ability of fermented ginger alone or certain other ingredients alone, which led to the completion of the present invention. In other words, they have found that by combining fermented ginger with certain other ingredients, the liver function improving ability can be synergistically improved.
すなわち、本発明は、発酵ショウガと特定の他成分とを含むことを特徴とする肝機能改善剤に関する。 That is, the present invention relates to a liver function improving agent that contains fermented ginger and other specific ingredients.
本発明によれば、肝機能改善作用に優れた肝機能改善剤を提供することができる。 The present invention provides a liver function improving agent that has excellent liver function improving effects.
本発明の肝機能改善剤としては、発酵ショウガ及び特定の他成分を含むものであれば特に制限されるものではなく、本発明の肝機能改善剤は優れた肝機能改善作用を有する。優れた肝機能改善作用により、肝機能の亢進または肝障害の抑制が期待でき、より具体的には、肝血流の増加、胆汁分泌促進、肝臓組織呼吸促進、脂肪の肝臓への蓄積の阻止もしくは抑制、ウィルス性・薬剤性・アルコール性肝障害抑制などの作用を高めることが期待できる。 The liver function improving agent of the present invention is not particularly limited as long as it contains fermented ginger and other specific ingredients, and the liver function improving agent of the present invention has an excellent liver function improving effect. Due to the excellent liver function improving effect, it is expected to enhance liver function or suppress liver damage, and more specifically, it is expected to enhance the effects of increasing hepatic blood flow, promoting bile secretion, promoting liver tissue respiration, preventing or suppressing accumulation of fat in the liver, and suppressing viral, drug-induced, and alcoholic liver damage.
[発酵ショウガ]
本発明における発酵ショウガは、ショウガ科植物を発酵させることにより、ジンゲロールがショウガオールに変換され、ショウガオールをジンゲロールよりも多く含むものである。特に、ショウガオールをジンゲロールよりも、1.0倍以上含むことが好ましく、1.1倍以上含むことがより好ましく、特に1.3倍以上含むことが好ましい。また、生のショウガより、ショウガオールを30倍以上含むことが好ましく、特に50倍以上含むことが好ましい。
[Fermented ginger]
The fermented ginger of the present invention is obtained by fermenting a Zingiberaceae plant, converting gingerol to shogaol, and contains more shogaol than gingerol. In particular, the fermented ginger contains preferably 1.0 times or more shogaol than gingerol, more preferably 1.1 times or more, and particularly preferably 1.3 times or more. Moreover, the fermented ginger contains preferably 30 times or more shogaol than raw ginger, and particularly preferably 50 times or more.
(原料)
本発明の肝機能改善剤の発酵ショウガの原料としては、ショウガ科の植物であれば特に制限されるものではなく、例えば、三州生姜、近江生姜、谷中生姜、金時生姜、静岡4号、黄生姜、土生姜、オタフク生姜等の各種ショウガを挙げることができる。本発明で用いられるショウガ科植物原料の形態としては、根茎をそのまま用いる他、スライス、粉砕物、搾汁、摩り下ろし、抽出物等として用いることができる。粉砕物としては、粉末、顆粒等が挙げられる。絞汁や抽出物は、液状であってもよいが、ペースト状や乾燥粉末として用いることもできる。抽出物は、適当な溶媒を用いて抽出することによって得ることができ、溶媒としては、例えば、水、エタノール、含水エタノールを用いることができる。使用する溶媒は、特に限定されないが、エタノールを含有する溶液を用いることが好ましく、例えば、ショウガ科植物の根茎を細かくしたものに、エタノール、あるいは含水エタノールを加えることで抽出物が得られる。この時、溶媒の添加量はショウガ科植物の総量に対して当量以上で添加し、添加後は60℃以上に加温しながら攪拌を行う。攪拌は1時間以上行い、攪拌後の溶液をろ過することで抽出液が得られる。この抽出液は濃縮して、適宜、量や濃度を調整することができる。
(material)
The raw material of the fermented ginger for the liver function improving agent of the present invention is not particularly limited as long as it is a plant of the Zingiberaceae family, and examples thereof include various gingers such as Sanshu ginger, Omi ginger, Yanaka ginger, Kintoki ginger, Shizuoka No. 4, Yellow ginger, Earth ginger, and Otafuku ginger. The form of the Zingiberaceae plant raw material used in the present invention can be the rhizome as it is, or it can be sliced, crushed, squeezed, grated, or extracted. Examples of the crushed material include powder and granules. The squeezed juice or extract can be in a liquid form, but can also be used in a paste form or dried powder form. The extract can be obtained by extraction using a suitable solvent, and examples of the solvent that can be used include water, ethanol, and aqueous ethanol. The solvent used is not particularly limited, but it is preferable to use a solution containing ethanol, and for example, an extract can be obtained by adding ethanol or aqueous ethanol to finely chopped rhizomes of Zingiberaceae plants. At this time, the amount of the solvent added is equal to or more than the total amount of Zingiberaceae plants, and after addition, the mixture is stirred while heating to 60°C or higher. The stirring is continued for at least one hour, and the solution after stirring is filtered to obtain an extract. The extract can be concentrated to adjust the amount and concentration as appropriate.
(発酵に用いる菌体)
ショウガ科植物原料を発酵させる方法としては、自家発酵、菌体又は酵素による発酵等が挙げられるが、発酵によって生じる代謝産物が多様であることから、菌体による発酵が好ましい。菌体としては、麹菌、酵母菌、乳酸菌、酢酸菌、枯草菌等の発酵に通常使用される菌体を用いることができ、本発明において用いられる菌体は一種であっても、二種以上であってもよい。本発明では、様々な酵素によってショウガ科植物のデンプン、タンパク質、繊維等を分解しうるため、特に麹菌を用いることが好ましい。
(Bacteria used in fermentation)
Methods for fermenting Zingiberaceae plant raw materials include self-fermentation, fermentation with fungal bodies or enzymes, etc., but fermentation with fungal bodies is preferred because of the variety of metabolic products produced by fermentation. As fungal bodies, fungal bodies commonly used for fermentation such as Aspergillus oryzae, yeast fungus, lactic acid bacteria, acetic acid bacteria, Bacillus subtilis, etc. can be used, and the fungal bodies used in the present invention may be one type or two or more types. In the present invention, it is particularly preferable to use Aspergillus oryzae, since it can decompose starch, protein, fiber, etc. of Zingiberaceae plants with various enzymes.
本発明において用いる麹菌としては、黒麹菌、白麹菌、黄麹菌、紅麹菌等が挙げられ、市販品を好適に使用することができる。具体的には、アスペルギルス・アワモリ(Aspergillus awamori)(黒麹菌)、アスペルギルス・サイトイ(Aspergillus saitoi)(黒麹菌)、アスペルギルス・ナカザワイ(Aspergillus nakazawai)(黒麹菌)、アスペルギルス・ウサミ(Aspergillus usamii)(黒麹菌)、アスペルギルス・ルーチェンシス(Aspergillus luchensis)(黒麹菌)、アスペルギルス・ニガー(Aspergillus niger)(黒麹菌)、アスペルギルス・カワチ(Aspergillus kawachii)(白麹菌)、アスペルギルス・オリゼー(Aspergillus oryzae)(黄麹菌)等のアスペルギルス属に属する麹菌を挙げることができる。 The koji mold used in the present invention may include black koji mold, white koji mold, yellow koji mold, red koji mold, etc., and commercially available products can be suitably used. Specifically, Aspergillus awamori (black koji mold), Aspergillus saitoi (black koji mold), Aspergillus nakazawai (black koji mold), Aspergillus usamii (black koji mold), Aspergillus luchensis (black koji mold), Aspergillus niger (black koji mold), Aspergillus kawachii (white koji mold), Aspergillus oryzae (Aspergillus oryzae (yellow koji mold) and other koji molds belonging to the genus Aspergillus.
酵母菌としては、例えば、デバリョマイセス属、サッカロマイセス属、ピチア属、クルイベロマイセス属、トルラスポラ属、シュビア属、ブレッタノマイセス属、クリプトコッカス属、エレモテリウム属、イッサチェンキア属、クロッケラ属、リポマイセス属、メトシュニコウイア属、ロードトルア属、シゾサッカロマイセス属、ジゴサッカロマイセス属、カンジダ属に属する菌体を挙げることができる。酵母菌株としては、前述の属に属するものであれば、特に限定されない。 Examples of yeast fungi include fungi belonging to the genera Debaryomyces, Saccharomyces, Pichia, Kluyveromyces, Torulaspora, Shuvia, Brettanomyces, Cryptococcus, Eremotherium, Issachenkia, Krokkera, Lipomyces, Metschnikowia, Rhodotorua, Schizosaccharomyces, Zygosaccharomyces, and Candida. Yeast strains are not particularly limited as long as they belong to the above-mentioned genera.
乳酸菌としては、例えば、桿菌のラクトバシラス属やビフィドバクテリウム属、球菌のロイコノストック属、ペディオコッカス属、ストレプトコッカス属、ラクトコッカス属の乳酸菌が挙げられるが、その他、エンテロコッカス属、バゴコッカス属、カルノバクテリウム属、アエロコッカス属、テトラゲノコッカス属等の乳酸菌を利用することができる。乳酸菌株としては、前述の属に属するものであれば、特に限定されない。 Examples of lactic acid bacteria include lactic acid bacteria of the genera Lactobacillus and Bifidobacterium, which are bacilli, and lactic acid bacteria of the genera Leuconostoc, Pediococcus, Streptococcus, and Lactococcus, which are cocci. In addition, lactic acid bacteria of the genera Enterococcus, Bagococcus, Carnobacterium, Aerococcus, and Tetragenococcus can also be used. There is no particular limitation on the lactic acid bacteria strain, so long as it belongs to the above-mentioned genera.
枯草菌としては、例えば、バシラス属の菌株等が挙げられる。枯草菌株としては、前述の属に属するものであれば、特に限定されない。 Examples of Bacillus subtilis include strains of the genus Bacillus. There are no particular limitations on the Bacillus subtilis strains as long as they belong to the above-mentioned genus.
酢酸菌としては、例えばアセトバクター属、アサイア属、アシドモナス属等が挙げられる。酢酸菌株としては、前述の属に属するものであれば、特に限定されない。 Examples of acetic acid bacteria include the genera Acetobacter, Asaia, and Acidomonas. There are no particular limitations on the acetic acid bacteria strains as long as they belong to the above-mentioned genera.
(発酵方法)
具体的な本発明の肝機能改善剤の発酵ショウガの製造方法としては、例えば、ショウガ科植物を菌体の発酵液と混合した後、30~90℃の条件の下、120~500時間といった長時間をかけて熟成を行う方法(長時間製法)や、ショウガ科植物原料を発酵させる発酵工程と、発酵物に対してショウガ科植物原料を添加する添加工程と、ショウガ科植物原料を添加した発酵物を、加圧下、100℃を超える温度で加熱処理する加熱工程とを有する製法(短時間製法)を挙げることができる。長時間製法は、発酵時又は発酵後に比較的低温の加熱で長時間かけて製造するという方法であり、短時間製法は、発酵物に一旦未発酵のショウガ科植物原料を加え、その後、加圧条件下の高い温度で加熱処理を行う方法である。長時間製法では、原料を添加する工程がなく、高圧加熱処理も行わないため、短時間製法よりも比較的コストが低く、発酵ショウガを製造することができる。短期間製法では、原料を添加する工程や高圧加熱処理を行うため、長時間製法よりもコストが掛かるが、短時間で発酵ショウガを得ることが出来る。
(Fermentation method)
Specific examples of the method for producing fermented ginger for the liver function improving agent of the present invention include a method in which a ginger plant is mixed with a fermentation liquid of a fungus body and then aged for a long time such as 120 to 500 hours under conditions of 30 to 90°C (long-term production method), and a production method having a fermentation step of fermenting a ginger plant raw material, an addition step of adding the ginger plant raw material to the fermented product, and a heating step of heat-treating the fermented product to which the ginger plant raw material has been added at a temperature exceeding 100°C under pressure (short-time production method). The long-time production method is a method in which the ginger plant raw material is produced over a long period of time by heating at a relatively low temperature during or after fermentation, and the short-time production method is a method in which an unfermented ginger plant raw material is once added to the fermented product and then heat-treated at a high temperature under pressure. The long-time production method does not have a step of adding raw materials and does not perform high-pressure heating treatment, so fermented ginger can be produced at a relatively lower cost than the short-time production method. The short-term process is more expensive than the long-term process because it involves adding ingredients and high-pressure heating, but it can produce fermented ginger in a short time.
ここで、長時間製法についてさらに説明する。 Here we will explain the long-term manufacturing process in more detail.
長時間製法のショウガ科植物原料を発酵させる発酵工程において、発酵は、例えば、温度30℃~90℃、湿度50%~90%の条件下で、3日間~30日間、好ましくは4日間~25日間、より好ましくは5日間~22日間加熱することが好ましい。 In the fermentation process for fermenting the ginger family plant material using the long-term method, the fermentation is preferably performed under conditions of a temperature of 30°C to 90°C and a humidity of 50% to 90%, for example, for 3 to 30 days, preferably 4 to 25 days, and more preferably 5 to 22 days.
また、ショウガ科植物を発酵後、加熱熟成することにより、ショウガオール類の量を生ショウガの含有量よりも、その含有量を2倍以上に富化することが出来る。 Furthermore, by fermenting ginger family plants and then heat-aging them, the amount of gingerols can be enriched to more than twice the content in fresh ginger.
具体的に、長時間製法による本発明の発酵ショウガの製造方法としては、例えば、ショウガ科植物を発酵液と混合した後、30~90℃の条件の下、120~500時間かけて熟成を行うことができる。 Specifically, in the method for producing fermented ginger of the present invention using a long-term production method, for example, a plant of the Zingiberaceae family can be mixed with a fermentation liquid and then aged for 120 to 500 hours under conditions of 30 to 90°C.
本発明で用いる長時間製法による本発明の発酵ショウガは、市販されているものを用いても良い。市販品を用いる場合は、生ショウガと比較して、発酵によってショウガオールの含有量が50倍以上となる発酵ショウガを用いることが好ましい。 The fermented ginger of the present invention produced by the long-term manufacturing method used in the present invention may be commercially available. When using a commercially available product, it is preferable to use fermented ginger that has a gingerol content of 50 times or more as a result of fermentation compared to raw ginger.
つぎに、短時間製法についてさらに説明する。 Next, we will explain the short-time manufacturing method in more detail.
短時間製法のショウガ科植物原料を発酵させる発酵工程において、発酵は、例えば、温度5~70℃、好ましくは10~40℃、より好ましくは15~30℃、さらに好ましくは30℃未満の条件で、1~30日間、好ましくは3~14日間行うことが好ましい。 In the fermentation process for fermenting the ginger family plant material using the short-time process, the fermentation is preferably carried out, for example, at a temperature of 5 to 70°C, preferably 10 to 40°C, more preferably 15 to 30°C, and even more preferably below 30°C, for 1 to 30 days, preferably 3 to 14 days.
発酵工程は、上述の発酵方法と同様である。続く添加工程は、発酵工程で用いたショウガ科植物原料と同じものを用いることが好ましいが、その種類や形態が異なるものを用いてもよい。ショウガ科植物原料の添加量としては、発酵工程において用いるショウガ科植物原料1質量部に対して、0.5~50質量部であることが好ましく、1~30質量部であることが好ましく、1.5~15質量部であることがさらに好ましい。 The fermentation step is the same as the fermentation method described above. In the subsequent addition step, it is preferable to use the same Zingiberaceae plant raw material as used in the fermentation step, but a different type or form may also be used. The amount of Zingiberaceae plant raw material added is preferably 0.5 to 50 parts by mass, preferably 1 to 30 parts by mass, and more preferably 1.5 to 15 parts by mass per part by mass of the Zingiberaceae plant raw material used in the fermentation step.
添加工程に続く加熱工程は、加圧下、100℃を超える温度で加熱処理する工程であり、添加工程において添加したショウガ科植物原料の発酵が十分に進まない程度の時間内に処理を行う(開始する)ことが好ましい。具体的に、例えば、添加工程の処理後、12時間以内に加熱工程の処理を行うことが好ましく、6時間以内に行うことがより好ましく、3時間以内に行うことがさらに好ましく、1時間以内に行うことが特に好ましい。 The heating step following the adding step is a step of heat treatment under pressure at a temperature exceeding 100°C, and it is preferable to carry out (start) the treatment within a time period in which the fermentation of the ginger family plant material added in the adding step does not proceed sufficiently. Specifically, for example, after the adding step, it is preferable to carry out the heating step within 12 hours, more preferably within 6 hours, even more preferably within 3 hours, and particularly preferably within 1 hour.
加熱条件としては、加熱温度が、105~200℃であることが好ましく、105~180℃であることがより好ましく、105~150℃であることがさらに好ましく、105~120℃であることが特に好ましい。また、加熱時間が、1~24時間であることが好ましく、1~12時間であることがより好ましく、1~10時間であることがさらに好ましい。加熱工程後は、例えば、噴霧乾燥、凍結乾燥等といった乾燥処理を施すことができる。 As for heating conditions, the heating temperature is preferably 105 to 200°C, more preferably 105 to 180°C, even more preferably 105 to 150°C, and particularly preferably 105 to 120°C. The heating time is preferably 1 to 24 hours, more preferably 1 to 12 hours, and even more preferably 1 to 10 hours. After the heating step, a drying process such as spray drying or freeze drying can be performed.
長時間製法及び短時間製法共に、ショウガ科植物原料に菌体を作用させる方法としては、ショウガ科植物原料に菌体やその培養液を噴霧又は添加する方法、ショウガ科植物原料を菌体の培養液に浸漬又は添加する方法や、菌体やその培養液から抽出した酵素を噴霧又は添加する方法等を挙げることができ、菌体の培養液としては、合成又は天然の培地を用いて培養した培養液、植物由来の培養液や、動物由来の培養液等を例示することができる。 In both the long-term and short-term manufacturing methods, methods for allowing fungal cells to act on Zingiberaceae plant raw materials include spraying or adding fungal cells or their culture solution to Zingiberaceae plant raw materials, immersing or adding Zingiberaceae plant raw materials in a culture solution of fungal cells, and spraying or adding enzymes extracted from fungal cells or their culture solution. Examples of culture solutions for fungal cells include culture solutions cultured using synthetic or natural media, culture solutions derived from plants, and culture solutions derived from animals.
菌体の培養液としては、菌体が有機物を発酵させた発酵物を用いることができ、有機物としては植物や、動物のいずれも利用することができるが、植物の発酵物が好ましい。用いることができる植物としては、特に限定されないが、米、玄米、大麦、小麦、トウモロコシ等の各種穀物、大豆、小豆、エンドウ豆等の豆類、シイタケ、マッシュルーム等のキノコ類、リンゴ、バナナ、オレンジ、ナシ、イチゴ、モモ、カキ、ブドウ、サクランボ、アプリコット等の果実類、レタス、キャベツ、甜菜、ほうれん草、ヨモギ、ハスの根、ゴボウ、大根、カブ、ニンジン、ナス、トマト、ブロッコリー、カリフラワー、タマネギ、セロリ、ネギ、ニラ、ラッキョウ、ショウガ、ウコン、バレイショ、サツマイモ、サトウキビ、茶、オリーブ、アシタバ、ケール、ニガウリ、ゴマ等の各種野菜、アーモンド、カシューナッツ、マカデミアナッツ、クリ、クルミ等の各種ナッツ類等が挙げられる。1種または2種以上を組み合わせて使用しても良い。これら植物を生のまま使用しても良いし、蒸す、茹でる等の加工をした後、菌体を加えて発酵させても良い。またその際には加水してもよい。 As the culture medium for the fungus, a fermented product obtained by fermenting organic matter with the fungus can be used. The organic matter can be either a plant or an animal, but a plant fermented product is preferred. Plants that can be used include, but are not limited to, various grains such as rice, brown rice, barley, wheat, and corn, beans such as soybeans, red beans, and peas, mushrooms such as shiitake mushrooms and mushrooms, fruits such as apples, bananas, oranges, pears, strawberries, peaches, persimmons, grapes, cherries, and apricots, various vegetables such as lettuce, cabbage, sugar beet, spinach, mugwort, lotus root, burdock, radish, turnip, carrot, eggplant, tomato, broccoli, cauliflower, onion, celery, green onion, Chinese chive, shallot, ginger, turmeric, potato, sweet potato, sugar cane, tea, olive, angelica tree, kale, bitter melon, and sesame, and various nuts such as almonds, cashew nuts, macadamia nuts, chestnuts, and walnuts. One or more of these may be used in combination. These plants may be used raw, or may be processed by steaming, boiling, or the like, and then fermented by adding fungal cells. Water may also be added during this process.
これらの発酵物は、発酵物そのものを用いることができるが、酢、味噌、酒等を製造する際のモロミや発酵後に残った粕等を使用しても良い。 These fermented products can be used as they are, but mash from the production of vinegar, miso, sake, etc., or lees left over after fermentation can also be used.
ショウガ科植物原料を菌体又は菌体の培養液から抽出した酵素の溶液と混合し、菌体やその培養液から抽出した酵素によって、混合物自体を発酵させても良い。この時、混合物を加熱することで、ジンゲロール類のショウガオール類への変換を促進することができる。 The raw material from the Zingiberaceae plant may be mixed with a solution of enzymes extracted from the fungus or the culture medium of the fungus, and the mixture itself may be fermented by the enzymes extracted from the fungus or its culture medium. At this time, the conversion of gingerols to shogaols can be promoted by heating the mixture.
また、動物由来の発酵物としては、特に限定されないが、ウシ科動物などのミルクの発酵物を利用することができる。特に牛乳は市販されており、安価で手に入りやすいので好ましい。 Furthermore, the fermented product derived from an animal is not particularly limited, but may be a fermented product of milk from bovine animals. In particular, cow's milk is preferable because it is commercially available, inexpensive, and easy to obtain.
本発明の肝機能改善剤として用いる発酵ショウガの形態としては、発酵して得られたショウガをそのまま用いる他、粉砕物、抽出物等として用いることができる。粉砕物としては、ペースト状、粉末、顆粒等が挙げられる。抽出物は、液状であってもよいが、ペースト状や乾燥粉末として用いることもできる。抽出物は、適当な溶媒を用いて抽出することによって得ることができ、溶媒としては、例えば、水、エタノール、含水エタノールを用いることができる。 The form of the fermented ginger used as the liver function improving agent of the present invention may be the ginger obtained by fermentation as it is, or it may be used as a crushed product, extract, etc. Examples of crushed products include paste, powder, granules, etc. The extract may be in liquid form, but it can also be used as a paste or dry powder. The extract can be obtained by extraction using an appropriate solvent, and examples of the solvent that can be used include water, ethanol, and aqueous ethanol.
長時間製法による本発明における発酵ショウガは、ジンゲロールに対してショウガオールが重量比で1:1.1~1000の範囲であることが好ましく、1:1.2~500の範囲であることがより好ましく、さらに1:1.3~200の範囲であることが好ましい。
また、短時間製法による本発明における発酵ショウガは、ジンゲロールに対してショウガオールが重量比で1.1~1000の範囲であることが好ましく、1:1.2~500の範囲であることがより好ましく、さらに1:1.2~200の範囲であることが好ましい。
In the fermented ginger of the present invention produced by the long-term production method, the weight ratio of gingerol to shogaol is preferably in the range of 1:1.1-1000, more preferably in the range of 1:1.2-500, and further preferably in the range of 1:1.3-200.
In addition, the fermented ginger of the present invention produced by the short-time production method has a weight ratio of gingerol to shogaol in the range of preferably 1.1 to 1000, more preferably 1:1.2 to 500, and even more preferably 1:1.2 to 200.
[他成分]
本発明の糖化阻害剤は、発酵ショウガと特定の他成分とを含むことを特徴とし、特定の他成分としては、コラゲナーゼ阻害能がほとんどないか、その能力が小さい他成分を、発酵ショウガと組み合わせることにより、コラゲナーゼ阻害能を相乗的に向上させることができる成分であれば限定されないが、特に以下に記載する(a)~(f)からなる群より選ばれる少なくとも1種の成分とを含むことが望ましい。
[Other ingredients]
The glycation inhibitor of the present invention is characterized by containing fermented ginger and specific other components. The specific other components are not limited as long as they have little or only low collagenase inhibitory activity and can synergistically improve the collagenase inhibitory activity when combined with fermented ginger, but it is particularly desirable for the glycation inhibitor to contain at least one component selected from the group consisting of (a) to (f) described below.
(a)飲料系植物素材
本発明の肝機能改善剤においては、発酵ショウガと共に他成分として、バラ、プーアール、コーヒー、ルイボス、紅茶及び豆乳から選ばれる少なくとも1種の飲料系植物素材を用いることが好ましい。これらの他成分は、発酵ショウガと組み合わせた場合に、相乗的な肝機能改善作用が得られるだけでなく、発酵ショウガの辛味や雑味などの呈味を改善することができる。また、発酵ショウガの独特の発酵臭を改善し、香り高く風味も好ましいものとすることができる。さらに、水に発酵ショウガのみを溶解した場合よりも、色味に優れ、また分散性に優れたものとすることができる。
(a) Beverage Plant Material In the liver function improving agent of the present invention, it is preferable to use at least one beverage plant material selected from rose, pu-erh, coffee, rooibos, black tea and soy milk as other components together with fermented ginger. When these other components are combined with fermented ginger, they can not only obtain a synergistic liver function improving effect, but also improve the taste of fermented ginger, such as the spiciness and unpleasant taste. They can also improve the unique fermented odor of fermented ginger, making it fragrant and flavorful. Furthermore, they can be made to have a better color and dispersibility than when only fermented ginger is dissolved in water.
これらの飲料系植物素材は、花、葉、茎、根等、植物のいずれの部位であってもよいが、通常茶として用いられる部位が好ましく、植物素材そのもの(乾燥物を含む)、その粉砕物、搾汁、抽出物、エキス等を用いることができる。粉砕物としては、粉末、顆粒等が挙げられる。搾汁や抽出物は、液状であってもよいが、ペースト状や乾燥粉末として用いることもできる。抽出物は、適当な溶媒を用いて抽出することによって得ることができ、溶媒としては、例えば、水、エタノール、含水エタノールを用いることができる。 These beverage plant materials may be any part of the plant, such as flowers, leaves, stems, or roots, but the parts normally used for tea are preferred. The plant material itself (including dried products), crushed products, squeezed juice, extracts, and essences can be used. Examples of crushed products include powders and granules. The squeezed juice and extracts may be in liquid form, but can also be used in the form of a paste or dried powder. Extracts can be obtained by extraction using an appropriate solvent, and examples of the solvent that can be used include water, ethanol, and aqueous ethanol.
バラはバラ科バラ属に属する植物であって、通常、花や実が用いられる。プーアールは、中華人民共和国雲南省を原産地とする中国茶(黒茶)の一種であって、生茶と熟茶があり、通常、葉や芽が用いられる。コーヒーは、アカネ科コーヒーノキ属に属する植物であって、種子を焙煎し挽いた粉末が用いられる。ルイボスは、マメ科アスパラトゥス属に属する植物であって、通常、葉や枝が用いられる。紅茶は、Camellia sinensisの生の茶の葉や芽を萎凋させ、揉捻し、完全発酵させ、乾燥させた茶葉が用いられる。豆乳はマメ科ダイズ属に属する植物の種子を加工したものであって、種子を直接搾汁したものか、種子を煮てから搾汁したものが用いられる。 Roses are plants belonging to the genus Rosaceae and the flowers and fruits are usually used. Pu-erh is a type of Chinese tea (black tea) originating from Yunnan Province in the People's Republic of China. It comes in both raw and ripe varieties, and the leaves and buds are usually used. Coffee is a plant belonging to the genus Coffea in the family Rubiaceae and the seeds are roasted and ground into powder. Rooibos is a plant belonging to the genus Aspalathus in the family Fabaceae and the leaves and branches are usually used. Black tea is made from raw tea leaves and buds of Camellia sinensis that have been withered, rolled, fully fermented, and dried. Soy milk is made from the seeds of a plant belonging to the genus Glycine in the family Fabaceae and is made by squeezing the juice directly from the seeds or by boiling and squeezing the juice from the seeds.
(b)香辛料
本発明の肝機能改善剤においては、発酵ショウガと共に他成分として、ターミナリア、ザクロ、ヒハツ、ユズ、クコ、ケイヒ、白インゲン、紅参及びヨモギから選ばれる少なくとも1種の香辛料を用いることが好ましい。なお、本発明においては、これらの成分を配合さえしていればよく、香りや辛味を出すなど、いわゆる香辛料の機能を発揮することを目的として配合していなくともよい。これらの他成分は、発酵ショウガと組み合わせた場合に、相乗的な肝機能改善作用が得られるだけでなく、発酵ショウガの辛味や雑味などの呈味を改善することができる。また発酵ショウガの独特の発酵臭を改善し、香り高く風味も好ましいものとすることができる。さらに、水に発酵ショウガのみを溶解した場合よりも、色味に優れ、また分散性に優れたものとすることができる。
(b) Spices In the liver function improving agent of the present invention, it is preferable to use at least one spice selected from terminalia, pomegranate, long pepper, yuzu, wolfberry, cinnamon, white kidney bean, red ginseng and mugwort as other ingredients together with fermented ginger. In the present invention, it is sufficient to blend these ingredients, and they do not have to be blended for the purpose of exerting the so-called spice function such as giving off a fragrance or a pungent taste. When these other ingredients are combined with fermented ginger, they can not only obtain a synergistic liver function improving effect, but also improve the taste such as the pungent taste and unpleasant taste of fermented ginger. They can also improve the unique fermented odor of fermented ginger, making it fragrant and flavorful. Furthermore, they can be made to have a better color and dispersibility than when only fermented ginger is dissolved in water.
これらの香辛料は、種子、実、花、葉、茎、根等、植物のいずれの部位であってもよいが、通常香辛料として用いられる部位が好ましく、植物素材そのもの(乾燥物を含む)、その粉砕物、搾汁、抽出物、エキス等を用いることができる。粉砕物としては、粉末、顆粒等が挙げられる。絞汁や抽出物は、液状であってもよいが、ペースト状や乾燥粉末として用いることもできる。抽出物は、適当な溶媒を用いて抽出することによって得ることができ、溶媒としては、例えば、水、エタノール、含水エタノールを用いることができる。 These spices may be any part of the plant, such as seeds, fruits, flowers, leaves, stems, roots, etc., but parts that are usually used as spices are preferred, and the plant material itself (including dried products), crushed products, squeezed juice, extracts, etc. can be used. Examples of crushed products include powders and granules. The squeezed juice and extracts may be in liquid form, but can also be used in the form of a paste or dried powder. Extracts can be obtained by extraction using an appropriate solvent, and examples of the solvent that can be used include water, ethanol, and aqueous ethanol.
ターミナリアとしては、例えば、Terminalia bellirica(belerica)、Terminalia catappa、Terminalia tomentosa、Terminalia citrina、Terminalia phellocarpa、Terminalia copelandii、Terminalia brassi、Terminalia ivorensis、Terminalia superba、Terminalia arjuna、Terminalia chebula等を挙げることができ、これらの中でも、Terminalia bellirica(belerica)、Terminalia chebulaが好ましい。本発明の植物素材として用いる部位としては、果実が好ましい。 Examples of Terminalia include Terminalia bellirica (belerica), Terminalia catappa, Terminalia tomentosa, Terminalia citrina, Terminalia phellocarpa, Terminalia copelandii, Terminalia brassi, Terminalia ivorensis, Terminalia superba, Terminalia arjuna, Terminalia chebula, etc., and among these, Terminalia bellirica (belerica) and Terminalia chebula are preferred. The part of the plant used as the plant material of the present invention is preferably the fruit.
(c)植物由来成分
本発明の肝機能改善剤においては、発酵ショウガと共に他成分として、ジャガイモ抽出物、松樹皮抽出物、葛花処理物、セサミン、カフェイン、クロロゲン酸、大豆タンパク、クルクミン、ピペリン、ジンセノサイド及びテアフラビンから選ばれる少なくとも1種の植物由来成分を用いることが好ましい。これらの他成分は、発酵ショウガと組み合わせた場合に、相乗的な肝機能改善作用が得られるだけでなく、発酵ショウガの辛味や雑味などの呈味を改善することができる。また発酵ショウガの独特の発酵臭を改善し、香り高く風味も好ましいものとすることができる。さらに、水に発酵ショウガのみを溶解した場合よりも、色味に優れ、また分散性に優れたものとすることができる。
(c) Plant-derived components In the liver function improving agent of the present invention, it is preferable to use at least one plant-derived component selected from potato extract, pine bark extract, processed kudzu flower, sesamin, caffeine, chlorogenic acid, soy protein, curcumin, piperine, ginsenoside and theaflavin as other components together with fermented ginger. When these other components are combined with fermented ginger, they can not only obtain a synergistic liver function improving effect, but also improve the taste of fermented ginger, such as the spiciness and unpleasant taste. They can also improve the unique fermented odor of fermented ginger, making it fragrant and flavorful. Furthermore, they can be made to have a better color and dispersibility than when only fermented ginger is dissolved in water.
ジャガイモ抽出物としては、例えば男爵薯、メークイン、キタアカリ、とうや、トヨシロ、インカのめざめ、デジマ、十勝こがねなどの根茎の抽出物が挙げられる。ジャガイモ抽出物としては、市販されているものを使用することができる。 Potato extracts include, for example, extracts from the roots of potatoes such as Danshaku potato, May Queen, Kitaakari, Touya, Toyoshiro, Inka no Mezame, Dejima, and Tokachi Kogane. Commercially available potato extracts can be used.
松樹皮抽出物としては、例えば、フランス海岸松(Pinus Martima)、カラマツ、クロマツ、アカマツ等の樹皮の抽出物が挙げられ、これらの中でも、プロアントシアニジンが豊富に含まれるフランス海岸松(Pinus Martima)の樹皮の抽出物が好ましい。松樹皮抽出物としては、市販されているものを使用することができる。 Examples of pine bark extracts include bark extracts of French maritime pine (Pinus Martima), larch, black pine, red pine, etc., and among these, an extract of the bark of French maritime pine (Pinus Martima), which is rich in proanthocyanidins, is preferred. Commercially available pine bark extracts can be used.
葛花処理物としては、マメ科クズ属に属する植物の花の処理物が用いられる。葛花処理物としては、市販されているものを使用することができる。 As the processed kudzu flower product, a processed product of the flowers of a plant belonging to the genus Pueraria of the family Leguminosae is used. As the processed kudzu flower product, a commercially available product can be used.
セサミン、カフェイン、クロロゲン酸、大豆タンパク、クルクミン、ピペリン、ジンセノサイド及びテアフラビンはいずれも、特に限定されないが、市販されているものを用いてもよく、植物から抽出、分離及び精製したものを用いてもよく、抽出物をそのまま使用しても良く、抽出物を乾燥させた粉末や顆粒等であっても良い。植物由来成分は、適当な溶媒を用いて抽出することによって得ることができ、溶媒としては、例えば、水、エタノール、含水エタノールを用いることができる。 Sesamin, caffeine, chlorogenic acid, soy protein, curcumin, piperine, ginsenoside and theaflavin are not particularly limited, and may be commercially available products, or may be extracted, separated and purified from plants. The extract may be used as is, or may be dried into powder or granules. The plant-derived components can be obtained by extraction using an appropriate solvent, and examples of the solvent that can be used include water, ethanol and aqueous ethanol.
(d)発酵物
本発明の肝機能改善剤においては、他成分として、青トウガラシ発酵物及び麹から選ばれる少なくとも1種の発酵物を用いることが好ましい。この他成分は、発酵ショウガと組み合わせた場合に、相乗的な肝機能改善作用が得られるだけでなく、発酵ショウガの辛味や雑味などの呈味を改善することができる。また、香り高く風味も好ましいものとすることができる。さらに、水に発酵ショウガのみを溶解した場合よりも、色味に優れ、また分散性に優れたものとすることができる。
(d) Fermented product In the liver function improving agent of the present invention, it is preferable to use at least one fermented product selected from green chili fermented product and koji as another component. When combined with fermented ginger, this other component not only provides a synergistic liver function improving effect, but also improves the taste of fermented ginger, such as its spiciness and unpleasant taste. It also has a rich fragrance and a pleasant flavor. Furthermore, it has a better color and dispersibility than when only fermented ginger is dissolved in water.
この発酵物は、特に限定されないが、発酵物をそのまま用いても良く、発酵物を乾燥させて、粉砕したものでも良い。また、発酵物から抽出したものであっても良く、抽出物をそのままその粉砕して用いることができる。粉砕物としては、粉末、顆粒等が挙げられる。抽出物は、液状であってもよいが、ペースト状や乾燥粉末として用いることもできる。抽出物は、適当な溶媒を用いて抽出することによって得ることができ、溶媒としては、例えば、水、エタノール、含水エタノールを用いることができる。 The fermented product is not particularly limited, but may be used as is, or may be a fermented product that has been dried and pulverized. It may also be an extract from the fermented product, and the extract may be pulverized and used as is. Examples of pulverized products include powder and granules. The extract may be in liquid form, but can also be used in paste form or as a dry powder. The extract can be obtained by extraction using a suitable solvent, and examples of the solvent that can be used include water, ethanol, and aqueous ethanol.
青トウガラシ発酵エキスは、特に限定されないが、市販されているものを用いてもよい。 The green pepper fermented extract is not particularly limited, but commercially available products may be used.
麹は、特に限定されないが、コメ、ムギ、ダイズ、アワ、ヒエ、キビ等の穀物を麹菌で発酵させたものであれば良い。発酵に用いる麹菌としては、黄麹菌、青麹菌、白麹菌、黒麹菌、紅麹等のいずれを用いても良い。具体的には、アスペルギルス・アワモリ(Aspergillus awamori)(黒麹菌)、アスペルギルス・サイトイ(Aspergillus saitoi)(黒麹菌)、アスペルギルス・ナカザワイ(Aspergillus nakazawai)(黒麹菌)、アスペルギルス・ウサミ(Aspergillus usamii)(黒麹菌)、アスペルギルス・ルーチェンシス(Aspergillus luchensis)(黒麹菌)、アスペルギルス・ニガー(Aspergillus niger)(黒麹菌)、アスペルギルス・カワチ(Aspergillus kawachii)(白麹菌)、アスペルギルス・オリゼー(Aspergillus oryzae)(黄麹菌)等のアスペルギルス属に属する麹菌を挙げることができる。中でも特に、紅麹を用いることが好ましい。 There are no particular limitations on the koji, but it may be made by fermenting grains such as rice, wheat, soybean, foxtail millet, barnyard millet, and millet with koji mold. The koji mold used for fermentation may be any of yellow koji mold, blue koji mold, white koji mold, black koji mold, red koji mold, and the like. Specifically, Aspergillus awamori (black koji mold), Aspergillus saitoi (black koji mold), Aspergillus nakazawai (black koji mold), Aspergillus usamii (black koji mold), Aspergillus luchensis (black koji mold), Aspergillus niger (black koji mold), Aspergillus kawachii (white koji mold), Aspergillus oryzae (Aspergillus oryzae (yellow koji mold), and other koji molds belonging to the genus Aspergillus. Among these, red koji mold is particularly preferred.
(e)アミノ酸
本発明の肝機能改善剤においては、発酵ショウガと共に他成分として、L-アラニン、L-アルギニン、L-グルタミン酸、L-グルタミン、L-シスチン、L-セリン、L-チロシン、L-ヒスチジン、L-ヒドロキシプロリン、L-イソロイシン、L-プロリン及びL-リシンから選ばれる少なくとも1種のアミノ酸(塩を含む)を用いることが好ましい。塩としては、例えば、ナトリウム塩、塩酸塩等を挙げることができる。これらの他成分は、発酵ショウガと組み合わせた場合に、相乗的な肝機能改善作用が得られるだけでなく、発酵ショウガの辛味や雑味などの呈味を改善することができる。また発酵ショウガの独特の発酵臭を改善し、香り高く風味も好ましいものとすることができる。さらに、水に発酵ショウガのみを溶解した場合よりも、色味に優れ、また分散性に優れたものとすることができる。
(e) Amino Acids In the liver function improving agent of the present invention, it is preferable to use at least one amino acid (including a salt) selected from L-alanine, L-arginine, L-glutamic acid, L-glutamine, L-cystine, L-serine, L-tyrosine, L-histidine, L-hydroxyproline, L-isoleucine, L-proline and L-lysine as another component together with fermented ginger. Examples of the salt include sodium salt and hydrochloride. When these other components are combined with fermented ginger, not only can they provide a synergistic liver function improving effect, but they can also improve the taste of fermented ginger, such as its spiciness and unpleasant taste. They can also improve the unique fermented odor of fermented ginger, making it fragrant and flavorful. Furthermore, they can be made to have a better color and dispersibility than when only fermented ginger is dissolved in water.
(f)機能性添加剤
本発明の肝機能改善剤においては、発酵ショウガと共に他成分として、鉄、ビタミンB2、ビタミンB3、ビタミンK、ピロロキノリンキノン、キサンタンガム、シェラック及びグァーガムから選ばれる少なくとも1種の機能性添加剤を用いることが好ましい。なお、本発明の機能性添加剤としての鉄は、これらの金属を含む化合物の形態を含む。これらの他成分は、発酵ショウガと組み合わせた場合に、相乗的な肝機能改善作用が得られるだけでなく、発酵ショウガの辛味や雑味などの呈味を改善することができる。また発酵ショウガの独特の発酵臭を改善し、香り高く風味も好ましいものとすることができる。さらに、水に発酵ショウガのみを溶解した場合よりも、色味に優れ、また分散性に優れたものとすることができる。
(f) Functional additives In the liver function improving agent of the present invention, it is preferable to use at least one functional additive selected from iron, vitamin B2, vitamin B3, vitamin K, pyrroloquinoline quinone, xanthan gum, shellac and guar gum as other components together with fermented ginger. The iron as the functional additive of the present invention includes the form of a compound containing these metals. When these other components are combined with fermented ginger, not only can they obtain a synergistic liver function improving effect, but they can also improve the taste of fermented ginger, such as its spiciness and unpleasant taste. They can also improve the unique fermented odor of fermented ginger, making it fragrant and flavorful. Furthermore, they can be made to have a better color and dispersibility than when only fermented ginger is dissolved in water.
(使用の形態)
本発明の肝機能改善剤は、発酵ショウガのみ又は他成分のみを含むものに比して向上した肝機能改善作用を有するものである。肝機能改善の用途に用いられる点において、製品として他の製品と区別できるものであればよく、例えば、本発明の肝機能改善剤に係る製品の本体、包装、説明書、宣伝物のいずれかに肝機能改善の機能がある旨を表示したものを挙げることができる。
(Form of Use)
The liver function improving agent of the present invention has an improved liver function improving effect compared to those containing only fermented ginger or only other ingredients. It is sufficient that the product can be distinguished from other products in terms of being used for improving liver function, and for example, the liver function improving agent of the present invention may be indicated to have a function of improving liver function on the product itself, packaging, instruction manual, or advertising material.
本発明の肝機能改善剤の利用形態としては、具体的には、医薬品(医薬部外品を含む)、化粧品、特定保健用食品、栄養機能食品、機能性表示食品等の所定機関より効能の表示が認められた機能性食品などのいわゆる健康食品等を挙げることができる。 Specific examples of applications of the liver function improving agent of the present invention include so-called health foods, such as pharmaceuticals (including quasi-drugs), cosmetics, foods for specified health uses, foods with nutrient function claims, and functional foods whose efficacy has been approved by a designated organization, such as functional foods.
本発明の肝機能改善剤は、外用又は経口用として使用することができる。外用剤としては、皮膚、頭皮等に塗布して用いるものであれば、特に制限はなく、その形態としては、軟膏剤、クリーム剤、ジェル剤、ローション剤、乳液剤、パック剤、湿布剤等の皮膚外用剤や、注射剤等の形態を挙げることができる。 The liver function improving agent of the present invention can be used externally or orally. There are no particular limitations on the external preparation, so long as it is applied to the skin, scalp, etc., and the form of the external preparation can be, for example, an ointment, cream, gel, lotion, emulsion, pack, poultice, or injection.
また、本発明の肝機能改善剤を経口剤として用いる場合、その形態としては、例えば、錠剤、カプセル剤、粉末剤、顆粒剤、液剤、粒状剤、棒状剤、板状剤、ブロック状剤、固形状剤、丸状剤、ペースト状剤、クリーム状剤、カプレット状剤、ゲル状剤、チュアブル状剤、スティック状剤等を挙げることができる。これらの中でも、摂取がしやすく、肝機能改善効果が得られやすいことから錠剤、カプセル剤、粉末剤、顆粒剤、液剤の形態が特に好ましい。具体的には、サプリメント、食品添加剤、ペットボトル、缶、瓶等に充填された容器詰飲料、水(湯)、牛乳、果汁、青汁等に溶解して飲むためのインスタント粉末(顆粒)飲料等を例示することができる。これらは食事の際などに手軽に飲食しやすく、また嗜好性を高めることができるという点で好ましい。 When the liver function improving agent of the present invention is used as an oral preparation, its form may be, for example, a tablet, capsule, powder, granule, liquid, granular, bar, plate, block, solid, pill, paste, cream, caplet, gel, chewable, or stick. Among these, the tablet, capsule, powder, granule, or liquid forms are particularly preferred because they are easy to ingest and have a liver function improving effect. Specific examples include supplements, food additives, packaged beverages filled in PET bottles, cans, bottles, etc., and instant powder (granule) beverages that are dissolved in water (hot water), milk, fruit juice, green juice, etc. and consumed. These are preferred because they are easy to eat and drink during meals and can be made more palatable.
本発明の肝機能改善剤における発酵ショウガ及び他成分の含有量としては、その効果の奏する範囲で適宜含有させればよく、発酵ショウガ及び(a)~(f)からなる群より選ばれる少なくとも1種の成分を有効成分として含むことが出来る。 The amount of fermented ginger and other ingredients contained in the liver function improving agent of the present invention may be appropriately determined within the range in which the effect is exhibited, and the agent may contain fermented ginger and at least one ingredient selected from the group consisting of (a) to (f) as active ingredients.
一般的には、本発明の肝機能改善剤が医薬品やサプリメント(錠剤,カプセル剤)の場合には、発酵ショウガ及び他成分が乾燥質量換算で全体の0.01~100質量%含まれていることが好ましく、0.1~85質量%含まれていることがより好ましく、0.5~70質量%含まれていることがさらに好ましい。 In general, when the liver function improving agent of the present invention is a medicine or supplement (tablets, capsules), the fermented ginger and other ingredients are preferably contained in an amount of 0.01 to 100% by mass, more preferably 0.1 to 85% by mass, and even more preferably 0.5 to 70% by mass, of the total amount calculated on a dry weight basis.
本発明の肝機能改善剤が容器詰飲料(液剤)である場合には、発酵ショウガ及び他成分が乾燥質量換算で全体の0.01~10質量%含まれていることが好ましく、0.03~6質量%含まれていることがより好ましく、0.05~4質量%含まれていることがさらに好ましい。 When the liver function improving agent of the present invention is a packaged beverage (liquid preparation), the fermented ginger and other ingredients are preferably contained in an amount of 0.01 to 10% by mass, more preferably 0.03 to 6% by mass, and even more preferably 0.05 to 4% by mass, of the total amount calculated on a dry mass basis.
また、本発明の肝機能改善剤がインスタント粉末飲料(粉末剤)、インスタント顆粒飲料(顆粒剤)である場合には、発酵ショウガ及び他成分が乾燥質量換算で全体の1~100質量%含まれていることが好ましく、5~90質量%含まれていることがより好ましく、10~80質量%含まれていることがさらに好ましい。 When the liver function improving agent of the present invention is an instant powdered drink (powder) or an instant granular drink (granule), the fermented ginger and other ingredients are preferably contained in an amount of 1 to 100% by mass, more preferably 5 to 90% by mass, and even more preferably 10 to 80% by mass, of the total amount calculated on a dry weight basis.
本発明の効果をより有効に発揮させるためには、発酵ショウガ及び他成分が乾燥質量換算で本発明の肝機能改善剤全体(水分を除く)の80質量%以上含まれていることが好ましく、90質量%以上含まれていることがより好ましく、95質量%以上含まれていることがさらに好ましく、100質量%であることが特に好ましい。 In order to more effectively exert the effects of the present invention, the fermented ginger and other ingredients are preferably contained in an amount of 80% by mass or more, more preferably 90% by mass or more, even more preferably 95% by mass or more, and particularly preferably 100% by mass, of the entire liver function improving agent of the present invention (excluding water) calculated on a dry mass basis.
本発明の肝機能改善剤の摂取量としては特に制限はないが、本発明の効果をより顕著に発揮させる観点から、1日当たりの発酵ショウガ及び他成分の摂取量が、50mg/日以上となるように摂取することが好ましく、100mg/日以上となるように摂取することがより好ましく、200mg/日以上となるように摂取することがさらに好ましい。その上限は特に制限されないが、例えば、8g/日であり、好ましくは4g/日である。本発明の肝機能改善剤は、1日の摂取量が前記摂取量となるように、1つの容器に、又は例えば2~3の複数の容器に分けて、1日分として収容することができる。 There is no particular limit to the amount of intake of the liver function improving agent of the present invention, but from the viewpoint of more significantly exerting the effects of the present invention, it is preferable to take fermented ginger and other ingredients so that the daily intake is 50 mg/day or more, more preferably 100 mg/day or more, and even more preferably 200 mg/day or more. The upper limit is not particularly limited, but is, for example, 8 g/day, preferably 4 g/day. The liver function improving agent of the present invention can be stored as a daily dose in one container or divided into multiple containers, for example, 2 to 3, so that the daily intake is the above-mentioned amount.
発酵ショウガ及び他成分の配合質量比としては、乾燥質量換算で、0.5:1~70:1の範囲であることが好ましく、0.75:1~60:1の範囲であることがより好ましく、1:1~60:1の範囲であることがさらに好ましく、1:1~50:1の範囲であることが特に好ましい。発酵ショウガ及び他成分の配合比が、上記範囲であることにより、本発明の効果をより有効に発揮することができる。 The blending ratio of fermented ginger to other ingredients is preferably in the range of 0.5:1 to 70:1, more preferably in the range of 0.75:1 to 60:1, even more preferably in the range of 1:1 to 60:1, and particularly preferably in the range of 1:1 to 50:1, in terms of dry mass. By having the blending ratio of fermented ginger to other ingredients in the above range, the effects of the present invention can be more effectively exhibited.
本発明の肝機能改善剤は、必要に応じて、経口用として許容される添加剤や、発酵ショウガ及び他成分以外の成分を添加して、公知の製剤方法によって製造することができる。 The liver function improving agent of the present invention can be produced by known formulation methods by adding, as necessary, additives acceptable for oral use and ingredients other than fermented ginger and other ingredients.
また、本発明の肝機能改善剤としては、発酵ショウガ及び他成分を含有する肝機能改善用食品の他、食品に対して発酵ショウガ及び他成分を添加して得た肝機能改善用食品を挙げることができ、例えば、通常の食品(天然の食品を含む)に比して本発明の発酵ショウガ及び他成分の含有量を増加させた食品や、本発明の発酵ショウガ及び他成分を通常含まない食品に対して発酵ショウガ及び他成分を添加した食品を挙げることができる。発酵ショウガ及び他成分の添加は、それぞれの成分を別々に添加してもよいし、同時に添加してもよく、また、発酵ショウガ及び他成分以外の他成分と共に添加してもよい。 In addition, examples of the liver function improving agent of the present invention include foods for improving liver function that contain fermented ginger and other ingredients, as well as foods for improving liver function obtained by adding fermented ginger and other ingredients to foods, such as foods in which the content of the fermented ginger and other ingredients of the present invention is increased compared to normal foods (including natural foods), and foods in which fermented ginger and other ingredients of the present invention have been added to foods that do not normally contain the fermented ginger and other ingredients. The fermented ginger and other ingredients may be added separately or simultaneously, or may be added together with ingredients other than the fermented ginger and other ingredients.
本発明の肝機能改善剤の使用形態の一つとして、食品に添加することができ、例えば、炭酸飲料、栄養飲料、果実飲料、乳酸飲料、スムージー、青汁等の飲料;アイスクリーム、アイスシャーベット、かき氷等の冷菓;そば、うどん、はるさめ、中華麺、即席麺等の麺類;飴、キャンディー、ガム、チョコレート、錠菓、スナック菓子、ビスケット、ゼリー、ジャム、クリーム、焼き菓子、パン等の菓子類;かまぼこ、ハム、ソーセージ等の水産・畜産加工食品;加工乳、発酵乳、ヨーグルト等の乳製品;サラダ油、てんぷら油、マーガリン、マヨネーズ、ショートニング、ホイップクリーム、ドレッシング等の油脂及びその加工食品;ソース、醤油等の調味料;カレー、シチュー、親子丼、お粥、雑炊、中華丼、かつ丼、天丼、牛丼、ハヤシライス、オムライス、おでん、マーボドーフ、餃子、シューマイ、ハンバーグ、ミートボール、各種ソース、各種スープ等のレトルトパウチ食品などを挙げることができる。 One of the ways in which the liver function improving agent of the present invention can be used is by adding it to foods, such as beverages such as carbonated drinks, nutritional drinks, fruit drinks, lactic acid drinks, smoothies, and green juice; frozen desserts such as ice cream, ice sherbet, and shaved ice; noodles such as soba, udon, harusame, Chinese noodles, and instant noodles; sweets such as candy, candy, gum, chocolate, tablet sweets, snacks, biscuits, jellies, jams, creams, baked goods, and bread; and processed seafood and livestock foods such as kamaboko, ham, and sausages. dairy products such as processed milk, fermented milk, yogurt, etc.; fats and oils such as salad oil, tempura oil, margarine, mayonnaise, shortening, whipped cream, dressing, etc. and processed foods made from them; seasonings such as sauces and soy sauce; retort pouch foods such as curry, stew, oyakodon, porridge, porridge, Chinese rice bowl, katsudon, tempura bowl, beef bowl, hayashi rice, omelet rice, oden, mapo dolphin, gyoza, shumai, hamburger steak, meatballs, various sauces, and various soups.
以下、本発明を実施例に基づき説明する。 The present invention will now be described with reference to examples.
[例1]
(発酵ショウガ1の製造方法)
米麹(市販の白麹で発酵させた白米)100gに水2Lを加えて作成した麹液に、洗浄し、4つ切り程度にした3.5kgの生ショウガを加え、10分浸漬した。浸漬後、麹液からショウガを取り出し、40℃~50℃にて14日間、発酵させた。発酵後、オートクレイブで120℃にて20分間殺菌し、殺菌後、75℃にて14日間熟成した。その後、熟成したショウガを乾燥して粉砕し、本発明の発酵ショウガ1を得た。
[Example 1]
(Method for producing fermented ginger 1)
3.5 kg of fresh ginger, which had been washed and cut into about four pieces, was added to a koji liquid prepared by adding 2 L of water to 100 g of rice koji (white rice fermented with commercially available white koji), and soaked for 10 minutes. After soaking, the ginger was removed from the koji liquid and fermented at 40°C to 50°C for 14 days. After fermentation, the ginger was sterilized in an autoclave at 120°C for 20 minutes, and then aged at 75°C for 14 days. The aged ginger was then dried and crushed to obtain fermented ginger 1 of the present invention.
(成分分析)
生ショウガ及び発酵ショウガ1に含まれるジンゲロール類、ショウガオール類の含有量を測定した。生ショウガ及び発酵ショウガ1のそれぞれを、アセトニトリル/水=20/80の抽出溶媒にて抽出した抽出液のジンゲロール類、ショウガオール類の含量を液体クロマトグラフィーにて測定した。なお測定には、HitachiHigh-Tech LaChromUltr
II C18カラムを用い、検出器はDAD (測定波長280nm) 10mm flow cellを用いた。移動相はA相に超純水、B相にアセトニトリルを用い、流量は0.7mL/min、カラム温度は40℃で測定を行った。
その結果、生ショウガのジンゲロール類、ショウガオール類の含有量は、ジンゲロール類 56mg/100g、ショウガオール類 1mg/100gであり、発酵ショウガ1のジンゲロール類、ショウガオール類の含有量は、ジンゲロール類 51mg/100g、ショウガオール類 78mg/100gであった。
(Component Analysis)
The contents of gingerols and shogaols in fresh ginger and fermented ginger 1 were measured. Fresh ginger and fermented ginger 1 were each extracted with an extraction solvent of acetonitrile/water = 20/80, and the contents of gingerols and shogaols in the extract were measured by liquid chromatography.
The II C18 column was used, and the detector was a DAD (measurement wavelength 280 nm) 10 mm flow cell. The mobile phase A was ultrapure water, and the mobile phase B was acetonitrile. The flow rate was 0.7 mL/min, and the column temperature was 40° C.
As a result, the contents of gingerols and shogaols in fresh ginger were 56 mg/100 g gingerols and 1 mg/100 g shogaols, while the contents of gingerols and shogaols in fermented ginger 1 were 51 mg/100 g gingerols and 78 mg/100 g shogaols.
発酵ショウガ1及び他成分を用いて、肝機能改善確認試験を行った。なお、発酵ショウガ1については、20倍量の60%エタノール中で約1時間ソニケ―ションし、遠心分離して得られた上清を濃縮及び乾燥させた乾燥粉末を試験に用いた。 A test was conducted to confirm the improvement of liver function using Fermented Ginger 1 and other ingredients. Fermented Ginger 1 was sonicated in 20 volumes of 60% ethanol for approximately 1 hour, centrifuged, and the supernatant was concentrated and dried to obtain a dry powder, which was used in the test.
[肝機能改善確認試験]
(サンプル液の調製)
10%FBS-DMEMで培養したヒト肝癌由来細胞(HepG2)を、トリプシン処理により浮遊させ、96well plateの各wellに2.0×104 cells/wellの細胞密度で播種した。37℃、5%CO2インキュベーター内で24時間前培養した。各wellより培地を除去後、10%FBS-DMEMを用いて所定濃度に調製した発酵ショウガ1、他成分、又はそれらを組み合わせたサンプルを100μLずつ添加し、CO2インキュベーター内で48時間培養した。発酵ショウガ1はDMSOに溶解し、DMSOの最終濃度が0.5%になるように所定濃度に調製後、フィルター滅菌し系列希釈した。黒胡椒、花椒、クコ、ゆず、ウコン、白インゲン、赤ショウガ、カプサイシン、ピペリン、βカロテン、クルクミン、セサミン、シェラック、ビタミンKはDMSOに溶解し、DMSOの終濃度が0.5%になるように所定濃度に調製後、フィルター滅菌し系列希釈した。上記以外の他成分については、試験物質を培地に溶解し、所定濃度に調製後、フィルター滅菌し系列希釈した。発酵ショウガ1と他成分とを組み合わせた試験区は、2倍濃度の試験物質含有培地を等量混合し所定濃度とした(DMSO最終濃度0.25%)。
[Liver function improvement confirmation test]
(Preparation of sample solution)
Human hepatoma-derived cells (HepG2) cultured in 10% FBS-DMEM were suspended by trypsinization and seeded in each well of a 96-well plate at a cell density of 2.0 x 10 4 cells/well. The cells were pre-cultured for 24 hours in a 5% CO 2 incubator at 37°C. After removing the medium from each well, 100 μL of fermented ginger 1, other ingredients, or a sample combining these, prepared to a predetermined concentration using 10% FBS-DMEM, was added and cultured for 48 hours in a CO 2 incubator. Fermented ginger 1 was dissolved in DMSO, adjusted to a predetermined concentration so that the final concentration of DMSO was 0.5%, and then filter-sterilized and serially diluted. Black pepper, Chinese pepper, Chinese wolfberry, yuzu, turmeric, white kidney bean, red ginger, capsaicin, piperine, β-carotene, curcumin, sesamin, shellac, and vitamin K were dissolved in DMSO, and the final concentration of DMSO was adjusted to a predetermined concentration of 0.5%, followed by filter sterilization and serial dilution. For other components other than those mentioned above, the test substance was dissolved in a medium, adjusted to a predetermined concentration, followed by filter sterilization and serial dilution. For the test group in which fermented ginger 1 was combined with other components, an equal amount of a medium containing a test substance at a double concentration was mixed to a predetermined concentration (DMSO final concentration 0.25%).
(測定方法)
48時間培養後、培地を除去し、無血清DMEMで30倍に希釈したCell Counting Kit-8溶液を150μL添加した。37℃、5%CO2インキュベーター内に静置し適度に発色させた後、450 nmにおける吸光度を測定した。
(Measuring method)
After 48 hours of culture, the medium was removed, and 150 μL of Cell Counting Kit-8 solution diluted 30-fold with serum-free DMEM was added. The cells were placed in a 37° C., 5% CO 2 incubator to allow appropriate color development, and then the absorbance at 450 nm was measured.
各試験物質の肝細胞賦活率は下記の式にて算出した。
肝細胞賦活率(%)
% of control = (Data sample-Data blank) /(Data control-Data blank)×100
(式中、Data sample:試験溶液(test)の吸光度
Data control:コントロール(test)の吸光度
Data blank:試験溶液(blank)の吸光度 )
The hepatocyte activation rate of each test substance was calculated according to the following formula.
Hepatocyte activation rate (%)
% of control = (Data sample - Data blank) / (Data control - Data blank) x 100
(Wherein, Data sample: absorbance of test solution (test)
Data control: Absorbance of the control (test)
Data blank: absorbance of test solution (blank)
その結果を表1~表7に示す。各試験区の変化値以外の数値は発酵ショウガ1又は他成分の最終濃度を示し、単位はいずれもμg/mLである。肝機能改善確認試験の結果はコントロールの肝細胞賦活率に対する変化値を示している。 The results are shown in Tables 1 to 7. Values other than the change value for each test group indicate the final concentration of fermented ginger 1 or other ingredients, all in μg/mL. The results of the liver function improvement confirmation test show the change value relative to the liver cell activation rate of the control.
表1のバラは市販されている花のエキス末を用いた。プーアールは市販の原料を、ビーズショッカー(回転数2,300rpm)にて20秒×7回粉砕した粉砕物を用いた。コーヒーは市販されている顆粒状のインスタントコーヒーを用いた。紅茶は市販されているティーパックのものを用いた。 For the rose in Table 1, a commercially available flower extract powder was used. For the Pu-erh, a commercially available raw material was used that was ground 7 times for 20 seconds in a bead shocker (rotation speed 2,300 rpm). For the coffee, commercially available instant granular coffee was used. For the black tea, commercially available tea bags were used.
表2のターミナリアは、ターミナリアベリリカの果実の水抽出物の乾燥末、ザクロは、市販されている花のエキス末、ヒハツは、市販されている果実の乾燥粉砕末、ケイヒは、市販されている乾燥粉末、白インゲンは、市販されている種子の乾燥粉末、紅参は、市販されている根茎の水抽出の乾燥末、ヨモギは、葉の乾燥粉末をそれぞれ用いた。 In Table 2, Terminalia is a dried powder of the water extract of Terminalia bellirica fruit, pomegranate is a commercially available powder of flower extract, long pepper is a commercially available dried and crushed powder of fruit, cinnamon is a commercially available dried powder, white kidney bean is a commercially available dried powder of seeds, red ginseng is a commercially available dried powder of the water extract of rhizome, and mugwort is a dried powder of leaves.
表3のジャガイモ抽出物は東洋新薬社製「ポテイン」、松樹皮抽出物は東洋新薬社製「フラバンジェノール」、葛花処理物は東洋新薬社製「葛の花エキス」をそれぞれ用いた。
表3に記載された松樹皮抽出物、ジャガイモ抽出物及び葛花処理物以外の他成分はすべて市販されているものを用いた。
The potato extract in Table 3 was "Potain" manufactured by Toyo Shinyaku Co., Ltd., the pine bark extract was "Flavangenol" manufactured by Toyo Shinyaku Co., Ltd., and the kudzu flower processed product was "Kudzu Flower Extract" manufactured by Toyo Shinyaku Co., Ltd.
All of the ingredients other than the pine bark extract, potato extract, and processed kudzu flower product listed in Table 3 were commercially available products.
表4の紅麹は市販されている紅麹菌と穀物(米、大豆など)とを発酵させてできた麹の乾燥粉砕末を用いた。 The red koji in Table 4 was made by fermenting commercially available red koji mold with grains (rice, soybeans, etc.), and using dried, ground koji powder.
表5に記載された他成分はすべて市販されているものを用いた。 All other ingredients listed in Table 5 were commercially available.
表6に記載された他成分はすべて市販されているものを用いた。 All other ingredients listed in Table 6 were commercially available.
表1~表6に示すように、長時間製法により製造された発酵ショウガ1と、本発明の特定の他成分を組み合わせることにより、肝細胞賦活率が相乗的に増加した。したがって、本発明肝機能改善剤は肝血流の増加、胆汁分泌促進、肝臓組織呼吸促進、脂肪の肝臓への蓄積の阻止もしくは抑制、ウィルス性・薬剤性・アルコール性肝障害抑制などの作用を高めることが出来る。 As shown in Tables 1 to 6, by combining fermented ginger 1 produced by the long-term manufacturing method with other specific components of the present invention, the liver cell activation rate was increased synergistically. Therefore, the liver function improving agent of the present invention can enhance the effects of increasing hepatic blood flow, promoting bile secretion, promoting liver tissue respiration, preventing or suppressing accumulation of fat in the liver, and suppressing viral, drug-induced, and alcoholic liver damage.
(比較例40~44)
例1と同じ手法を用いて、下記他成分の肝機能改善確認試験を行ったところ、飲料系植物素材である鉄観音(比較例40)、香辛料であるクコ(比較例41)、植物由来成分であるβ-カロテン(比較例42)、アミノ酸であるL-リシン(比較例43)及び機能性添加剤である重曹(炭酸水素ナトリウム、比較例44)については、肝細胞賦活の相乗作用は確認されなかった。
(Comparative Examples 40 to 44)
Using the same method as in Example 1, tests to confirm the liver function improvement of the following other ingredients were conducted. As a result, no synergistic effect in hepatocyte activation was confirmed for the beverage plant material Tieguanyin (Comparative Example 40), the spice Wolfberry (Comparative Example 41), the plant-derived ingredient β-carotene (Comparative Example 42), the amino acid L-lysine (Comparative Example 43), and the functional additive sodium bicarbonate (sodium bicarbonate, Comparative Example 44).
[例2]
(発酵ショウガ2の製造方法)
グルコース及び酵母エキスを含むGE培地(液体培地)に、黒麹菌であるA.awamoriを添加し、28℃にて2日間、液体用の培養タンクで培養した。その後、培養した培地の濃度が3.8%となるようにGE培地で希釈し、生ショウガを乾燥させたショウガの乾燥粉末を濃度が1%となるように添加した。このショウガの乾燥粉末を添加した培地を、28℃にて6日間、液体用の培養タンクで培養し、ショウガの乾燥粉末を発酵させた(発酵工程)。発酵後、発酵工程で用いたものと同じショウガの乾燥粉末を濃度が3%となるように添加した(添加工程)。添加後すぐに加圧条件下で115~120℃にて2時間、加熱処理を行った(加熱工程)。その後、凍結乾燥によって乾燥し(乾燥工程)、本発明の発酵ショウガ2を得た。
[Example 2]
(Method for producing fermented ginger 2)
A black koji mold A. awamori was added to a GE medium (liquid medium) containing glucose and yeast extract, and cultured in a liquid culture tank at 28 ° C. for 2 days. Thereafter, the cultured medium was diluted with GE medium so that the concentration was 3.8%, and dried ginger powder obtained by drying raw ginger was added to a concentration of 1%. The medium to which the dried ginger powder was added was cultured in a liquid culture tank at 28 ° C. for 6 days, and the dried ginger powder was fermented (fermentation process). After fermentation, the same dried ginger powder used in the fermentation process was added to a concentration of 3% (addition process). Immediately after the addition, heat treatment was performed at 115 to 120 ° C. under pressurized conditions for 2 hours (heating process). Then, it was dried by freeze-drying (drying process) to obtain fermented ginger 2 of the present invention.
(成分分析)
生ショウガ、ショウガの乾燥粉末及び発酵ショウガ2に含まれるジンゲロール類、ショウガオール類の含有量を測定した。測定は、例1と同様の手順で行った。
その結果、生ショウガのジンゲロール類、ショウガオール類の含有量は、ジンゲロール類 48.3mg/100g、ショウガオール類 1.7mg/100gであり、ショウガの乾燥粉末のジンゲロール類、ショウガオール類の含有量は、ジンゲロール類 1265mg/100g、ショウガオール類 129mg/100gであり、発酵ショウガ2のジンゲロール類、ショウガオール類の含有量は、ジンゲロール類 352mg/100g、ショウガオール類 466mg/100gであった。
(Component Analysis)
The contents of gingerols and shogaols in fresh ginger, dried ginger powder, and fermented ginger 2 were measured. The measurements were performed in the same manner as in Example 1.
As a result, the contents of gingerols and shogaols in fresh ginger were 48.3 mg/100 g of gingerols and 1.7 mg/100 g of shogaols, the contents of gingerols and shogaols in dry ginger powder were 1,265 mg/100 g of gingerols and 129 mg/100 g of shogaols, and the contents of gingerols and shogaols in fermented ginger 2 were 352 mg/100 g of gingerols and 466 mg/100 g of shogaols.
上記で得られた発酵ショウガ2及び他成分を用いて、肝機能改善確認試験を行った。 A liver function improvement test was conducted using the fermented ginger 2 and other ingredients obtained above.
[肝機能改善確認試験]
発酵ショウガ2、他成分、又はそれらを組み合わせたサンプルを所定濃度に調製する際に、無血清DMEMを用いたこと以外は、例1と同じ手順で試験を行った。
[Liver function improvement confirmation test]
The test was carried out in the same manner as in Example 1, except that serum-free DMEM was used to prepare samples of fermented ginger 2, other ingredients, or a combination thereof to a predetermined concentration.
その結果を表8~表13に示す。各試験区の変化値以外の数値は発酵ショウガ2又は他成分の最終濃度を示し、単位はいずれもμg/mLである。肝機能改善確認試験の結果はコントロールの肝細胞賦活率に対する変化値を示している。 The results are shown in Tables 8 to 13. Values other than the change value for each test group indicate the final concentration of fermented ginger 2 or other ingredients, all in μg/mL. The results of the liver function improvement confirmation test show the change value relative to the liver cell activation rate of the control.
表8のルイボスは市販の原料を、ビーズショッカー(回転数2,300rpm)にて20秒×7回粉砕した粉砕物、バラは市販されている花のエキス末、豆乳は市販されている豆乳粉末をそれぞれ用いた。 In Table 8, rooibos was made by crushing commercially available raw materials 7 times for 20 seconds using a bead shocker (rotation speed: 2,300 rpm), rose was made by using commercially available flower extract powder, and soy milk was made by using commercially available soy milk powder.
表9のユズは市販されている搾汁した後の種子を含む皮の乾燥粉砕末、クコは市販されている実の乾燥粉砕末、ケイヒは市販されている乾燥粉末、白インゲンは市販されている種子の乾燥粉末をそれぞれ用いた。 For yuzu in Table 9, commercially available dried and crushed skin including the seeds after squeezing the juice was used; for goji berries, commercially available dried and crushed fruit powder was used; for cinnamon, commercially available dried powder was used; and for white beans, commercially available dried seed powder was used.
表10のジャガイモ抽出物は、東洋新薬社製「ポテイン」を用いた。
表10に記載されたジャガイモ抽出物及び松樹皮抽出物以外の他成分はすべて市販されているものを用いた。
The potato extract in Table 10 used was "Potain" manufactured by Toyo Shinyaku Co., Ltd.
All ingredients other than the potato extract and pine bark extract listed in Table 10 were commercially available.
表11の青トウガラシ発酵物は、東洋新薬製の「青トウガラシ発酵エキス」、紅麹は市販されている紅麹菌と穀物(米、大豆など)とを発酵させてできた麹の乾燥粉砕末、多穀麹は、市販されている穀物麹(大麦・あわ・ひえ・きび・タカキビ・紫黒米・米粉)を麹菌で発酵させてできた麹の乾燥粉末をそれぞれ用いた。 The green chili fermented product in Table 11 is "green chili fermented extract" manufactured by Toyo Shinyaku, red koji is a dried powder of koji made by fermenting commercially available red koji mold with grains (rice, soybeans, etc.), and multi-grain koji is a dried powder of koji made by fermenting commercially available grain koji (barley, foxtail millet, barnyard millet, millet, hawk's sorghum, purple black rice, rice flour) with koji mold.
表12に記載された他成分はすべて市販されているものを用いた。 All other ingredients listed in Table 12 were commercially available.
表13に記載された他成分はすべて市販されているものを用いた。なお、鉄は塩化鉄を用いた。 All other ingredients listed in Table 13 are commercially available. Iron was used in the form of ferric chloride.
表8~表13に示すように、短時間製法により製造された発酵ショウガ2と、本発明の特定の他成分を組み合わせることにより、肝細胞賦活率が相乗的に増加した。したがって、本発明肝機能改善剤は肝血流の増加、胆汁分泌促進、肝臓組織呼吸促進、脂肪の肝臓への蓄積の阻止もしくは抑制、ウィルス性・薬剤性・アルコール性肝障害抑制などの作用を高めることが出来る。 As shown in Tables 8 to 13, by combining fermented ginger 2 produced by the short-time production method with other specific components of the present invention, the liver cell activation rate was synergistically increased. Therefore, the liver function improving agent of the present invention can enhance the effects of increasing hepatic blood flow, promoting bile secretion, promoting liver tissue respiration, preventing or suppressing accumulation of fat in the liver, and suppressing viral, drug-induced, and alcoholic liver damage.
(比較例81~85)
例2と同じ手法を用いて、下記他成分の肝機能改善確認試験を行ったところ、飲料系植物素材である鉄観音(比較例81)、香辛料であるヨモギ(比較例82)、植物由来成分であるβ-カロテン(比較例83)、アミノ酸であるL-イソロイシン(比較例84)及び機能性添加剤であるL-酒石酸(比較例85)については、肝細胞賦活の相乗作用は確認されなかった。
(Comparative Examples 81 to 85)
Using the same method as in Example 2, tests were conducted to confirm the liver function improvement of the following other ingredients. As a result, no synergistic effect in hepatocyte activation was confirmed for the beverage plant material Tieguanyin (Comparative Example 81), the spice Artemisia vulgaris (Comparative Example 82), the plant-derived ingredient β-carotene (Comparative Example 83), the amino acid L-isoleucine (Comparative Example 84), and the functional additive L-tartaric acid (Comparative Example 85).
(配合例1:化粧水)
全体を100質量部として、発酵ショウガ1抽出物 0.01質量部、松樹皮抽出物 0.01質量部、グリセリン 10質量部、ジグリセリン 3質量部、1,3-ブチレングリコール 12質量部、ペンチレングリコール 3質量部、ヒアルロン酸ナトリウム 0.1質量部、クエン酸 0.01質量部、クエン酸ナトリウム 0.02質量部、キサンタンガム 0.1質量部、メチルパラベン 0.15質量部、カルボマー 0.2質量部、水酸化ナトリウム 0.03質量部及び水 残部を混合して、化粧水の態様で本発明の肝機能改善用組成物を調製した。この化粧水は、相乗的な肝機能改善作用が得られるだけでなく、発酵ショウガ1の独特の発酵臭を改善し、香り高く、好ましいものであった。
(Formulation Example 1: Lotion)
The composition for improving liver function of the present invention was prepared in the form of a lotion by mixing 0.01 parts by mass of fermented ginger 1 extract, 0.01 parts by mass of pine bark extract, 10 parts by mass of glycerin, 3 parts by mass of diglycerin, 12 parts by mass of 1,3-butylene glycol, 3 parts by mass of pentylene glycol, 0.1 parts by mass of sodium hyaluronate, 0.01 parts by mass of citric acid, 0.02 parts by mass of sodium citrate, 0.1 parts by mass of xanthan gum, 0.15 parts by mass of methylparaben, 0.2 parts by mass of carbomer, 0.03 parts by mass of sodium hydroxide, and the remainder of the water, with the total amount being 100 parts by mass. This lotion not only provided a synergistic liver function improving effect, but also improved the unique fermented odor of fermented ginger 1, and was fragrant and preferable.
(配合例2:シャンプー)
全体を100質量部として、発酵ショウガ1抽出物 0.01質量部、ザクロ花エキス 0.02質量部、ラウレス硫酸ナトリウム 7.5質量部、コカミドプロピルベタイン 4.2質量部、コカミドDEA 3質量部、1,3-ブチレングリコール 0.1質量部、ポリクオタニウム-10 0.225質量部、クエン酸 0.15質量部、クエン酸ナトリウム 0.05質量部、フェノキシエタノール 0.9質量部及び水 残部を混合して、シャンプーの態様で本発明の肝機能改善用組成物を調製した。このシャンプーは、相乗的な肝機能改善作用が得られるだけでなく、発酵ショウガ1の独特の発酵臭を改善し、香り高く、好ましいものであった。
(Formulation example 2: Shampoo)
The composition for improving liver function of the present invention was prepared in the form of a shampoo by mixing 0.01 parts by weight of fermented ginger 1 extract, 0.02 parts by weight of pomegranate flower extract, 7.5 parts by weight of sodium laureth sulfate, 4.2 parts by weight of cocamidopropyl betaine, 3 parts by weight of cocamide DEA, 0.1 parts by weight of 1,3-butylene glycol, 0.225 parts by weight of polyquaternium-10, 0.15 parts by weight of citric acid, 0.05 parts by weight of sodium citrate, 0.9 parts by weight of phenoxyethanol, and the remainder of the water, taking the total as 100 parts by weight. This shampoo not only provided a synergistic liver function improving effect, but also improved the unique fermented odor of fermented ginger 1, and was fragrant and preferable.
(配合例3:石鹸)
全体を100質量部として、発酵ショウガ1粉砕物 0.5質量部、大豆タンパク0.5重量部、グリセリン 2質量部、オリーブ油 1質量部、EDTA-4ナトリウム 0.1質量部、エチドロン酸4ナトリウム 0.2質量部及び石ケン素地 残部を混合及び固化することにより、石鹸の態様で本発明の肝機能改善用組成物を調製した。この石鹸は、相乗的な肝機能改善作用が得られるだけでなく、発酵ショウガ1の独特の発酵臭を改善し、香り高く、好ましいものであった。
(Formulation Example 3: Soap)
The composition for improving liver function of the present invention was prepared in the form of soap by mixing and solidifying 0.5 parts by weight of pulverized fermented ginger 1, 0.5 parts by weight of soy protein, 2 parts by weight of glycerin, 1 part by weight of olive oil, 0.1 parts by weight of tetrasodium EDTA, 0.2 parts by weight of tetrasodium etidronate, and the remainder of the soap base, with the total weight being 100 parts by weight. This soap not only provided a synergistic liver function improving effect, but also improved the unique fermented odor of fermented ginger 1, and was fragrant and favorable.
(配合例4:乳液)
全体を100質量部として、発酵ショウガ1抽出物 0.1質量部、バラ花エキス 0.1質量部、ショ糖脂肪酸エステル 3質量部、グリセリン 12質量部、スクアラン 6質量部、ジメチルシリコーンオイル 24質量部、ポリプロピレングリコール 1質量部、増粘剤 0.06質量部、フェノキシエタノール 0.2質量部、エタノール 5質量部、水酸化ナトリウム 0.01質量部及び精製水 残部を混合して、乳液の態様で本発明の肝機能改善用組成物を調製した。この乳液は、相乗的な肝機能改善作用が得られるだけでなく、発酵ショウガ1の独特の発酵臭を改善し、香り高く、好ましいものであった。
(Formulation Example 4: Milk Lotion)
The composition for improving liver function of the present invention was prepared in the form of an emulsion by mixing 0.1 parts by mass of fermented ginger 1 extract, 0.1 parts by mass of rose flower extract, 3 parts by mass of sucrose fatty acid ester, 12 parts by mass of glycerin, 6 parts by mass of squalane, 24 parts by mass of dimethyl silicone oil, 1 part by mass of polypropylene glycol, 0.06 parts by mass of thickener, 0.2 parts by mass of phenoxyethanol, 5 parts by mass of ethanol, 0.01 parts by mass of sodium hydroxide, and the remaining part of purified water, with the total amount being 100 parts by mass. This emulsion not only provided a synergistic liver function improving effect, but also improved the unique fermented odor of fermented ginger 1, and was fragrant and preferable.
(配合例5:化粧用クリーム)
全体を100質量部として、発酵ショウガ1抽出物 0.1質量部、紅麹抽出物 0.1質量部、スクワラン 15.0質量部、ミリスチン酸オクチルドデシル 4.0質量部、水素添加大豆リン脂質 0.2質量部、ブチルアルコール 2.4質量部、硬化油 1.5質量部、ステアリン酸 1.5質量部、親油型モノステアリン酸グリセリン 1.5質量部、モノステアリン酸ポリグリセリル 0.5質量部、ベヘニルアルコール 0.8質量部、モノミリスチン酸ポリグリセリル 0.7質量部、サラシミツロウ 0.3質量部、d-δ-トコフェロール 0.1質量部、メチルパラベン 0.3質量部、C10~30アルキル変性カルボキシビニルポリマー 0.2質量部、カルボキシビニルポリマー 0.1質量部、1,3-ブタンジオール 18.0質量部、水酸化ナトリウム 0.1質量部及び精製水 残部を混合して、化粧用クリームの態様で本発明の肝機能改善用組成物を調製した。この化粧用クリームは、相乗的な肝機能改善作用が得られるだけでなく、発酵ショウガ1の独特の発酵臭を改善し、香り高く、好ましいものであった。
(Formulation Example 5: Cosmetic cream)
Based on a total of 100 parts by weight, fermented ginger 1 extract 0.1 parts by weight, red koji extract 0.1 parts by weight, squalane 15.0 parts by weight, octyldodecyl myristate 4.0 parts by weight, hydrogenated soybean phospholipid 0.2 parts by weight, butyl alcohol 2.4 parts by weight, hardened oil 1.5 parts by weight, stearic acid 1.5 parts by weight, lipophilic glycerin monostearate 1.5 parts by weight, polyglyceryl monostearate 0.5 parts by weight, behenyl alcohol 0.8 parts by weight, polyglyceryl monomyristate 0.7 parts by weight, white beeswax 0.3 parts by weight, d-δ-tocopherol 0.1 parts by weight, methylparaben 0.3 parts by weight, C10-30 alkyl modified carboxyvinyl polymer 0.2 parts by weight, carboxyvinyl polymer 0.1 parts by weight, 1,3-butanediol 18.0 parts by weight, sodium hydroxide The composition for improving liver function of the present invention was prepared in the form of a cosmetic cream by mixing 0.1 parts by mass of the fermented ginger 1 and the remainder purified water. This cosmetic cream not only provided a synergistic liver function improving effect, but also improved the unique fermented odor of fermented ginger 1, and was fragrant and favorable.
(配合例6:パック剤)
全体を100質量部として、発酵ショウガ1抽出物 0.1質量部、ピロロキノン 0.01質量部、ポリビニルアルコール 20.0質量部、グリセリン 5.0質量部、エタノール 20.0質量部、カオリン 6.0質量部、防腐剤 0.2質量部、香料 0.1質量部及び精製水 残部を混合して、パック剤の態様で本発明の肝機能改善用組成物を調製した。このパック剤は、相乗的な肝機能改善作用が得られるだけでなく、発酵ショウガ1の独特の発酵臭を改善し、香り高く、好ましいものであった。
(Formulation Example 6: Pack Agent)
The composition for improving liver function of the present invention is prepared in the form of a pack by mixing 0.1 parts by weight of fermented ginger 1 extract, 0.01 parts by weight of pyrroloquinone, 20.0 parts by weight of polyvinyl alcohol, 5.0 parts by weight of glycerin, 20.0 parts by weight of ethanol, 6.0 parts by weight of kaolin, 0.2 parts by weight of preservative, 0.1 parts by weight of perfume and the remaining part of purified water, with the total weight being 100 parts by weight. This pack not only provides synergistic liver function improving effect, but also improves the unique fermented odor of fermented ginger 1, and is fragrant and favorable.
(配合例7:錠剤)
全体を100質量部として、発酵ショウガ1粉末 10質量部、ターミナリアベリリカ果実抽出物 8質量部、ビタミンB1 5質量部、結晶性セルロース 20質量部、乳糖 50質量部、ステアリン酸マグネシウム 4質量部及びコーンスターチ 残部を混合及び打錠することにより、錠剤の態様で本発明の肝機能改善用組成物を調製した。この錠剤は、相乗的な肝機能改善作用が得られるだけでなく、発酵ショウガ1の辛味や雑味などの呈味が改善されていた。また、発酵ショウガ1の独特の発酵臭を改善し、香り高く風味も好ましいものであった。
(Formulation Example 7: Tablets)
The composition for improving liver function of the present invention was prepared in the form of a tablet by mixing and tableting 10 parts by weight of fermented ginger 1 powder, 8 parts by weight of Terminalia bellirica fruit extract, 5 parts by weight of vitamin B1, 20 parts by weight of crystalline cellulose, 50 parts by weight of lactose, 4 parts by weight of magnesium stearate, and the remaining part of cornstarch, with the total weight being 100 parts by weight. This tablet not only provided a synergistic liver function improving effect, but also improved the taste of fermented ginger 1, such as the spiciness and unpleasant taste. In addition, the unique fermented odor of fermented ginger 1 was improved, and the flavor was fragrant and favorable.
(配合例8:顆粒剤)
全体を100質量部として、発酵ショウガ粉末1 10質量部、コーヒー抽出物 15質量部、乳糖 10質量部、ステアリン酸カルシウム 1質量部及び結晶セルロース 残部を混合及び顆粒化することにより、顆粒剤の態様で本発明の肝機能改善用組成物を調製した。この顆粒剤は、相乗的な肝機能改善作用が得られるだけでなく、発酵ショウガ1の辛味や雑味などの呈味が改善されていた。また、発酵ショウガ1の独特の発酵臭を改善し、香り高く風味も好ましいものであった。
(Formulation Example 8: Granules)
The composition for improving liver function of the present invention was prepared in the form of granules by mixing and granulating 10 parts by mass of fermented ginger powder 1, 15 parts by mass of coffee extract, 10 parts by mass of lactose, 1 part by mass of calcium stearate, and the remaining part of crystalline cellulose, with the total amount being 100 parts by mass. This granule not only provided a synergistic liver function improving effect, but also improved the taste, such as the spiciness and unpleasant taste, of fermented ginger 1. In addition, the unique fermented odor of fermented ginger 1 was improved, resulting in a highly fragrant and pleasant flavor.
(配合例9:カプセル剤)
全体を100質量部として、発酵ショウガ1抽出物 10質量部、紅参粉砕末 20質量部、レシチン 8質量部及びオリーブ油 残部を混合して調製したものを内容液として、これをカプセル殻に内包することにより、カプセル剤の態様で本発明の肝機能改善用組成物を調製した。このカプセル剤は、相乗的な肝機能改善作用が得られるだけでなく、その内容物の発酵ショウガ1の辛味や雑味などの呈味が改善されていた。また内容物の発酵ショウガ1の独特の発酵臭を改善し、香り高く風味も好ましいものであった。
(Formulation Example 9: Capsules)
The composition for improving liver function of the present invention was prepared in the form of a capsule by mixing 10 parts by weight of fermented ginger 1 extract, 20 parts by weight of crushed red ginseng powder, 8 parts by weight of lecithin, and the remaining part of olive oil, with the total weight being 100 parts by weight, and encapsulating the mixture in a capsule shell to prepare a composition for improving liver function of the present invention. This capsule not only exhibited a synergistic liver function improving effect, but also improved the taste of the spiciness and unpleasant taste of the fermented ginger 1 contained therein. In addition, the unique fermented odor of the fermented ginger 1 contained therein was improved, and the flavor was fragrant and pleasant.
(配合例10:液剤)
全体を100質量部として、発酵ショウガ1エキス粉末 0.84質量部、プーアール茶抽出物 3.0質量部、果糖ブドウ糖液糖 10質量部、クエン酸 1質量部、安息香酸ナトリウム 0.02質量部、香料製剤 2質量部、スクラロース 0.05質量部、アセスルファムカリウム 0.03質量部及び精製水 残部を混合して、液剤の態様で本発明の肝機能改善用組成物を調製した。この液剤は、相乗的な肝機能改善作用が得られるだけでなく、発酵ショウガ1の辛味や雑味などの呈味が改善されていた。また、発酵ショウガ1の独特の発酵臭を改善し、香り高く風味も好ましいものであった。
(Formulation Example 10: Liquid)
The composition for improving liver function of the present invention was prepared in the form of a liquid by mixing 0.84 parts by mass of fermented ginger 1 extract powder, 3.0 parts by mass of Pu-erh tea extract, 10 parts by mass of fructose glucose liquid sugar, 1 part by mass of citric acid, 0.02 parts by mass of sodium benzoate, 2 parts by mass of flavor preparation, 0.05 parts by mass of sucralose, 0.03 parts by mass of acesulfame potassium, and the remaining part by mass of purified water, with the total amount being 100 parts by mass. This liquid not only provided a synergistic liver function improving effect, but also improved the taste of fermented ginger 1, such as the spiciness and unpleasant taste. In addition, the unique fermented odor of fermented ginger 1 was improved, and the fragrance and flavor were favorable.
(配合例11:化粧水)
全体を100質量部として、発酵ショウガ2抽出物 0.01質量部、豆乳パウダー 1質量部、グリセリン 10質量部、ジグリセリン 3質量部、1,3-ブチレングリコール 12質量部、ペンチレングリコール 3質量部、ヒアルロン酸ナトリウム 0.1質量部、クエン酸 0.01質量部、クエン酸ナトリウム 0.02質量部、キサンタンガム 0.1質量部、メチルパラベン 0.15質量部、カルボマー 0.2質量部、水酸化ナトリウム 0.03質量部及び水 残部を混合して、化粧水の態様で本発明の肝機能改善用組成物を調製した。この化粧水は、相乗的な肝機能改善作用が得られるだけでなく、発酵ショウガ2の独特の発酵臭を改善し、香り高く、好ましいものであった。
(Formulation Example 11: Lotion)
The composition for improving liver function of the present invention was prepared in the form of a lotion by mixing 0.01 parts by weight of fermented ginger 2 extract, 1 part by weight of soy milk powder, 10 parts by weight of glycerin, 3 parts by weight of diglycerin, 12 parts by weight of 1,3-butylene glycol, 3 parts by weight of pentylene glycol, 0.1 parts by weight of sodium hyaluronate, 0.01 parts by weight of citric acid, 0.02 parts by weight of sodium citrate, 0.1 parts by weight of xanthan gum, 0.15 parts by weight of methylparaben, 0.2 parts by weight of carbomer, 0.03 parts by weight of sodium hydroxide, and the remaining part of water, with the total weight being 100 parts by weight. This lotion not only provided a synergistic liver function improving effect, but also improved the unique fermented odor of fermented ginger 2, and was fragrant and preferable.
(配合例12:シャンプー)
全体を100質量部として、発酵ショウガ2抽出物 0.01質量部、バラ花エキス 0.02質量部、ラウレス硫酸ナトリウム 7.5質量部、コカミドプロピルベタイン 4.2質量部、コカミドDEA 3質量部、1,3-ブチレングリコール 0.1質量部、ポリクオタニウム-10 0.225質量部、クエン酸 0.15質量部、クエン酸ナトリウム 0.05質量部、フェノキシエタノール 0.9質量部及び水 残部を混合して、シャンプーの態様で本発明の肝機能改善用組成物を調製した。このシャンプーは、相乗的な肝機能改善作用が得られるだけでなく、発酵ショウガ2の独特の発酵臭を改善し、香り高く、好ましいものであった。
(Formulation Example 12: Shampoo)
The composition for improving liver function of the present invention was prepared in the form of a shampoo by mixing 0.01 parts by mass of fermented ginger 2 extract, 0.02 parts by mass of rose flower extract, 7.5 parts by mass of sodium laureth sulfate, 4.2 parts by mass of cocamidopropyl betaine, 3 parts by mass of cocamide DEA, 0.1 parts by mass of 1,3-butylene glycol, 0.225 parts by mass of polyquaternium-10, 0.15 parts by mass of citric acid, 0.05 parts by mass of sodium citrate, 0.9 parts by mass of phenoxyethanol, and the remainder of the water, taking the total as 100 parts by mass. This shampoo not only provided a synergistic liver function improving effect, but also improved the unique fermented odor of fermented ginger 2, and was fragrant and preferable.
(配合例13:石鹸)
全体を100質量部として、発酵ショウガ2粉砕物 0.5質量部、クコ実粉砕末 2質量部、オリーブ油 1質量部、EDTA-4ナトリウム 0.1質量部、エチドロン酸4ナトリウム 0.2質量部及び石ケン素地 残部を混合及び固化することにより、石鹸の態様で本発明の肝機能改善用組成物を調製した。この石鹸は、相乗的な肝機能改善作用が得られるだけでなく、発酵ショウガ2の独特の発酵臭を改善し、香り高く、好ましいものであった。
(Formulation Example 13: Soap)
The composition for improving liver function of the present invention was prepared in the form of soap by mixing and solidifying 0.5 parts by mass of pulverized fermented ginger 2, 2 parts by mass of pulverized wolfberry powder, 1 part by mass of olive oil, 0.1 part by mass of tetrasodium EDTA, 0.2 parts by mass of tetrasodium etidronate, and the remainder of the soap base, with the total amount being 100 parts by mass. This soap not only provided a synergistic liver function improving effect, but also improved the unique fermented odor of fermented ginger 2, and was fragrant and favorable.
(配合例14:乳液)
全体を100質量部として、発酵ショウガ2抽出物 0.1質量部、ジンセノサイド 0.1質量部、ショ糖脂肪酸エステル 3質量部、グリセリン 12質量部、スクアラン 6質量部、ジメチルシリコーンオイル 24質量部、ポリプロピレングリコール 1質量部、増粘剤 0.06質量部、フェノキシエタノール 0.2質量部、エタノール 5質量部、水酸化ナトリウム 0.01質量部及び精製水 残部を混合して、乳液の態様で本発明の肝機能改善用組成物を調製した。この乳液は、相乗的な肝機能改善作用が得られるだけでなく、発酵ショウガ2の独特の発酵臭を改善し、香り高く、好ましいものであった。
(Formulation Example 14: Emulsion)
The composition for improving liver function of the present invention was prepared in the form of an emulsion by mixing 0.1 parts by mass of fermented ginger 2 extract, 0.1 parts by mass of ginsenoside, 3 parts by mass of sucrose fatty acid ester, 12 parts by mass of glycerin, 6 parts by mass of squalane, 24 parts by mass of dimethyl silicone oil, 1 part by mass of polypropylene glycol, 0.06 parts by mass of thickener, 0.2 parts by mass of phenoxyethanol, 5 parts by mass of ethanol, 0.01 parts by mass of sodium hydroxide, and the remaining part of purified water, with the total amount being 100 parts by mass. This emulsion not only provides a synergistic liver function improving effect, but also improves the unique fermented odor of fermented ginger 2, and is fragrant and favorable.
(配合例15:化粧用クリーム)
全体を100質量部として、発酵ショウガ2抽出物 0.1質量部、紅麹抽出物 0.01質量部、スクワラン 15.0質量部、ミリスチン酸オクチルドデシル 4.0質量部、水素添加大豆リン脂質 0.2質量部、ブチルアルコール 2.4質量部、硬化油 1.5質量部、ステアリン酸 1.5質量部、親油型モノステアリン酸グリセリン 1.5質量部、モノステアリン酸ポリグリセリル 0.5質量部、ベヘニルアルコール 0.8質量部、モノミリスチン酸ポリグリセリル 0.7質量部、サラシミツロウ 0.3質量部、d-δ-トコフェロール 0.1質量部、メチルパラベン 0.3質量部、C10~30アルキル変性カルボキシビニルポリマー 0.2質量部、カルボキシビニルポリマー 0.1質量部、1,3-ブタンジオール 18.0質量部、水酸化ナトリウム 0.1質量部及び精製水 残部を混合して、化粧用クリームの態様で本発明の肝機能改善用組成物を調製した。この化粧用クリームは、相乗的な肝機能改善作用が得られるだけでなく、発酵ショウガ2の独特の発酵臭を改善し、香り高く、好ましいものであった。
(Formulation Example 15: Cosmetic cream)
Based on a total of 100 parts by weight, fermented ginger 2 extract 0.1 parts by weight, red koji extract 0.01 parts by weight, squalane 15.0 parts by weight, octyldodecyl myristate 4.0 parts by weight, hydrogenated soybean phospholipid 0.2 parts by weight, butyl alcohol 2.4 parts by weight, hardened oil 1.5 parts by weight, stearic acid 1.5 parts by weight, lipophilic glycerin monostearate 1.5 parts by weight, polyglyceryl monostearate 0.5 parts by weight, behenyl alcohol 0.8 parts by weight, polyglyceryl monomyristate 0.7 parts by weight, white beeswax 0.3 parts by weight, d-δ-tocopherol 0.1 parts by weight, methylparaben 0.3 parts by weight, C10-30 alkyl modified carboxyvinyl polymer 0.2 parts by weight, carboxyvinyl polymer 0.1 parts by weight, 1,3-butanediol 18.0 parts by weight, sodium hydroxide The composition for improving liver function of the present invention was prepared in the form of a cosmetic cream by mixing 0.1 parts by mass of the fermented ginger 2 and the remainder purified water. This cosmetic cream not only provided a synergistic liver function improving effect, but also improved the unique fermented odor of fermented ginger 2, and was fragrant and favorable.
(配合例16:パック剤)
全体を100質量部として、発酵ショウガ2抽出物 0.1質量部、ビタミンB2 0.01質量部、ポリビニルアルコール 20.0質量部、グリセリン 5.0質量部、エタノール 20.0質量部、カオリン 6.0質量部、防腐剤 0.2質量部、香料 0.1質量部及び精製水 残部を混合して、パック剤の態様で本発明の肝機能改善用組成物を調製した。このパック剤は、相乗的な肝機能改善作用が得られるだけでなく、発酵ショウガ2の独特の発酵臭を改善し、香り高く、好ましいものであった。
(Formulation Example 16: Pack Agent)
The composition for improving liver function of the present invention was prepared in the form of a pack by mixing 0.1 parts by weight of fermented ginger 2 extract, 0.01 parts by weight of vitamin B2, 20.0 parts by weight of polyvinyl alcohol, 5.0 parts by weight of glycerin, 20.0 parts by weight of ethanol, 6.0 parts by weight of kaolin, 0.2 parts by weight of preservative, 0.1 parts by weight of fragrance, and the remaining part of purified water, with the total weight being 100 parts by weight. This pack not only provides a synergistic liver function improving effect, but also improves the unique fermented odor of fermented ginger 2, and is fragrant and favorable.
(配合例17:錠剤)
全体を100質量部として、発酵ショウガ2粉末 10質量部、ルイボス粉砕末 8質量部、ビタミンB1 5質量部、結晶性セルロース 20質量部、乳糖 50質量部、ステアリン酸マグネシウム 4質量部及びコーンスターチ 残部を混合及び打錠することにより、錠剤の態様で本発明の肝機能改善用組成物を調製した。この錠剤は、相乗的な肝機能改善作用が得られるだけでなく、発酵ショウガ2の辛味や雑味などの呈味が改善されていた。また、発酵ショウガ2の独特の発酵臭を改善し、香り高く風味も好ましいものであった。
(Formulation Example 17: Tablets)
The composition for improving liver function of the present invention was prepared in the form of a tablet by mixing and tableting 10 parts by weight of fermented ginger 2 powder, 8 parts by weight of crushed rooibos powder, 5 parts by weight of vitamin B1, 20 parts by weight of crystalline cellulose, 50 parts by weight of lactose, 4 parts by weight of magnesium stearate, and the remaining part of cornstarch, with the total weight being 100 parts by weight. This tablet not only provided a synergistic liver function improving effect, but also improved the taste of fermented ginger 2, such as the spiciness and unpleasant taste. In addition, the unique fermented odor of fermented ginger 2 was improved, and the composition had a good fragrance and a pleasant flavor.
(配合例18:顆粒剤)
全体を100質量部として、発酵ショウガ2粉末 10質量部、ユズ粉砕末 15質量部、乳糖 10質量部、ステアリン酸カルシウム 1質量部及び結晶セルロース 残部を混合及び顆粒化することにより、顆粒剤の態様で本発明の肝機能改善用組成物を調製した。この顆粒剤は、相乗的な肝機能改善作用が得られるだけでなく、発酵ショウガ2の辛味や雑味などの呈味が改善されていた。また、発酵ショウガ2の独特の発酵臭を改善し、香り高く風味も好ましいものであった。
(Formulation Example 18: Granules)
The composition for improving liver function of the present invention was prepared in the form of granules by mixing and granulating 10 parts by mass of fermented ginger 2 powder, 15 parts by mass of crushed yuzu powder, 10 parts by mass of lactose, 1 part by mass of calcium stearate, and the remaining part of crystalline cellulose, with the total amount being 100 parts by mass. This granule not only provided a synergistic liver function improving effect, but also improved the taste of fermented ginger 2, such as the spiciness and unpleasant taste. In addition, the unique fermented odor of fermented ginger 2 was improved, and the aroma and flavor were favorable.
(配合例19:カプセル剤)
全体を100質量部として、発酵ショウガ2抽出物 10質量部、セサミン 20質量部、レシチン 8質量部及びオリーブ油 残部を混合して調製したものを内容液として、これをカプセル殻に内包することにより、カプセル剤の態様で本発明の肝機能改善用組成物を調製した。このカプセル剤は、相乗的な肝機能改善作用が得られるだけでなく、その内容物の発酵ショウガ2の辛味や雑味などの呈味が改善されていた。また内容物の発酵ショウガ2の独特の発酵臭を改善し、香り高く風味も好ましいものであった。
Formulation Example 19: Capsules
The composition for improving liver function of the present invention was prepared in the form of a capsule by mixing 10 parts by weight of fermented ginger 2 extract, 20 parts by weight of sesamin, 8 parts by weight of lecithin, and the remaining part of olive oil, with the total weight being 100 parts by weight, and encapsulating this in a capsule shell as the content liquid. This capsule not only provided a synergistic liver function improving effect, but also improved the taste of the content fermented ginger 2, such as the spiciness and unpleasant taste. In addition, the unique fermented odor of the content fermented ginger 2 was improved, and the fragrance and flavor were favorable.
(配合例20:液剤)
全体を100質量部として、発酵ショウガ2エキス粉末 0.84質量部、ルイボス茶エキス 2.5質量部、果糖ブドウ糖液糖 10質量部、クエン酸 1質量部、安息香酸ナトリウム 0.02質量部、香料製剤 2質量部、スクラロース 0.05質量部、アセスルファムカリウム 0.03質量部、及び精製水 残部を混合して、液剤の態様で本発明の肝機能改善用組成物を調製した。この液剤は、相乗的な肝機能改善作用が得られるだけでなく、発酵ショウガ2の辛味や雑味などの呈味が改善されていた。また、発酵ショウガ2の独特の発酵臭を改善し、香り高く風味も好ましいものであった。
(Formulation Example 20: Liquid)
The composition for improving liver function of the present invention was prepared in the form of a liquid by mixing 0.84 parts by mass of fermented ginger 2 extract powder, 2.5 parts by mass of rooibos tea extract, 10 parts by mass of fructose glucose liquid sugar, 1 part by mass of citric acid, 0.02 parts by mass of sodium benzoate, 2 parts by mass of flavor preparation, 0.05 parts by mass of sucralose, 0.03 parts by mass of acesulfame potassium, and the remaining part by mass of purified water, with the total amount being 100 parts by mass. This liquid not only provided a synergistic liver function improving effect, but also improved the taste of fermented ginger 2, such as the spiciness and unpleasant taste. In addition, the unique fermented odor of fermented ginger 2 was improved, and the fragrance and flavor were favorable.
Claims (1)
A liver function improving agent comprising fermented ginger and at least one component selected from the group consisting of sesamin, fermented green pepper, long pepper, and red ginseng.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023014833A JP7489136B2 (en) | 2020-01-27 | 2023-02-02 | Liver function improver |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020010978A JP6883356B2 (en) | 2020-01-27 | 2020-01-27 | Liver function improving agent |
| JP2021074184A JP7226843B2 (en) | 2020-01-27 | 2021-04-26 | Liver function improver |
| JP2023014833A JP7489136B2 (en) | 2020-01-27 | 2023-02-02 | Liver function improver |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021074184A Division JP7226843B2 (en) | 2020-01-27 | 2021-04-26 | Liver function improver |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023041873A JP2023041873A (en) | 2023-03-24 |
| JP7489136B2 true JP7489136B2 (en) | 2024-05-23 |
Family
ID=70386791
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020010978A Active JP6883356B2 (en) | 2020-01-27 | 2020-01-27 | Liver function improving agent |
| JP2021074184A Active JP7226843B2 (en) | 2020-01-27 | 2021-04-26 | Liver function improver |
| JP2023014833A Active JP7489136B2 (en) | 2020-01-27 | 2023-02-02 | Liver function improver |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020010978A Active JP6883356B2 (en) | 2020-01-27 | 2020-01-27 | Liver function improving agent |
| JP2021074184A Active JP7226843B2 (en) | 2020-01-27 | 2021-04-26 | Liver function improver |
Country Status (1)
| Country | Link |
|---|---|
| JP (3) | JP6883356B2 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6714928B2 (en) | 2016-02-12 | 2020-07-01 | 株式会社東洋新薬 | Collagenase inhibitor |
| JP6883356B2 (en) * | 2020-01-27 | 2021-06-09 | 株式会社東洋新薬 | Liver function improving agent |
| JP7246455B1 (en) | 2021-11-11 | 2023-03-27 | アサヒ飲料株式会社 | Beverage containing acetic acid |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014010656A1 (en) | 2012-07-11 | 2014-01-16 | 興和株式会社 | Superior blood alcohol concentration reduction accelerating agent |
| JP2014221735A (en) | 2013-05-13 | 2014-11-27 | 株式会社エヌ・エル・エー | Hepatocyte activator comprising shogaols as active ingredient, and solid pharmaceutical formulation, liquid pharmaceutical formulation and functional food comprising the hepatocyte activator |
| JP2015188442A (en) | 2014-03-31 | 2015-11-02 | 公益財団法人サントリー生命科学財団 | Plant cultured cells for producing sesamin and method for producing sesamin using the same |
| CN105011256A (en) | 2014-04-21 | 2015-11-04 | 冯松平 | Vinegar drink capable of losing weight |
| KR20160010909A (en) | 2014-07-20 | 2016-01-29 | 원유용 | Natural beauty soap for the improvement and treatment of the Eczema.acne, psoriasis, seborrheic skin using White Ionic Minerals, SY2220, and White Ionic Minerals distilled water, SY2216, extracted from white clay of Yang Gu Bangsan region and manufacturing method and that compositions. |
| JP2017141199A (en) | 2016-02-12 | 2017-08-17 | 株式会社東洋新薬 | Liver function improver |
| KR101967073B1 (en) | 2017-12-27 | 2019-04-08 | 주식회사 풀무원 | Composition for enhancing immunity comprising fermented ginger extract and red ginseng extract |
| JP2020063302A (en) | 2020-01-27 | 2020-04-23 | 株式会社東洋新薬 | Liver function improver |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101167802B (en) * | 2006-10-25 | 2011-04-20 | 中国科学院上海生命科学研究院 | Preparation method of cinnamon extract, cinnamon extract, composition and use thereof |
| JP2013079227A (en) * | 2011-09-20 | 2013-05-02 | Nla:Kk | Metabolism-enhancing composition, and functional food including the metabolism-enhancing composition |
| JP6429705B2 (en) * | 2015-03-30 | 2018-11-28 | 株式会社エヌ・エル・エー | Composition for reducing blood neutral fat and functional food for reducing blood neutral fat |
-
2020
- 2020-01-27 JP JP2020010978A patent/JP6883356B2/en active Active
-
2021
- 2021-04-26 JP JP2021074184A patent/JP7226843B2/en active Active
-
2023
- 2023-02-02 JP JP2023014833A patent/JP7489136B2/en active Active
Patent Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014010656A1 (en) | 2012-07-11 | 2014-01-16 | 興和株式会社 | Superior blood alcohol concentration reduction accelerating agent |
| JP2014221735A (en) | 2013-05-13 | 2014-11-27 | 株式会社エヌ・エル・エー | Hepatocyte activator comprising shogaols as active ingredient, and solid pharmaceutical formulation, liquid pharmaceutical formulation and functional food comprising the hepatocyte activator |
| JP2015188442A (en) | 2014-03-31 | 2015-11-02 | 公益財団法人サントリー生命科学財団 | Plant cultured cells for producing sesamin and method for producing sesamin using the same |
| CN105011256A (en) | 2014-04-21 | 2015-11-04 | 冯松平 | Vinegar drink capable of losing weight |
| KR20160010909A (en) | 2014-07-20 | 2016-01-29 | 원유용 | Natural beauty soap for the improvement and treatment of the Eczema.acne, psoriasis, seborrheic skin using White Ionic Minerals, SY2220, and White Ionic Minerals distilled water, SY2216, extracted from white clay of Yang Gu Bangsan region and manufacturing method and that compositions. |
| JP2017141199A (en) | 2016-02-12 | 2017-08-17 | 株式会社東洋新薬 | Liver function improver |
| KR101967073B1 (en) | 2017-12-27 | 2019-04-08 | 주식회사 풀무원 | Composition for enhancing immunity comprising fermented ginger extract and red ginseng extract |
| JP2020063302A (en) | 2020-01-27 | 2020-04-23 | 株式会社東洋新薬 | Liver function improver |
| JP2021107445A (en) | 2020-01-27 | 2021-07-29 | 株式会社東洋新薬 | Liver function improver |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2021107445A (en) | 2021-07-29 |
| JP6883356B2 (en) | 2021-06-09 |
| JP2020063302A (en) | 2020-04-23 |
| JP2023041873A (en) | 2023-03-24 |
| JP7226843B2 (en) | 2023-02-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6682073B2 (en) | Liver function improver | |
| JP7537757B2 (en) | Collagenase Inhibitors | |
| JP6758623B2 (en) | Absorption enhancer for shogaol and / or gingerol | |
| JP7489136B2 (en) | Liver function improver | |
| JP6811948B2 (en) | Glycation inhibitor | |
| JP5090014B2 (en) | Fermented composition and food, beverage and pharmaceutical product using the composition | |
| JP2025157605A (en) | Liver function improver | |
| JP2025074334A (en) | Composition for suppressing increase in blood neutral fat | |
| JP2010265251A (en) | Blood flow promoting agent | |
| JP7112786B2 (en) | Absorption enhancer for shogaol and/or gingerol | |
| JP2025031752A (en) | Glycation inhibitors | |
| JP2010265215A (en) | Methioninase inhibitor | |
| JP7539717B2 (en) | Shogaol and/or gingerol absorption enhancer | |
| JP2020193216A (en) | Absorption-promoting agent of shogaol and/or gingerol | |
| JP2008163003A (en) | Fat absorption inhibitor | |
| KR20180073812A (en) | Cosmetic composition for anti-oxidant and skin whitening effect comprising buckwheat seed extract of specific germination condition as effective component | |
| JP2007112721A (en) | Melanin production inhibiting composition and food and drink containing the same | |
| KR20020054291A (en) | Manufacturing method of food containing substance becoming medicine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20230222 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20240122 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240313 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20240408 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20240502 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7489136 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |